WO2000018365A2 - Fast dissolving orally consumable films - Google Patents
Fast dissolving orally consumable films Download PDFInfo
- Publication number
- WO2000018365A2 WO2000018365A2 PCT/US1999/022115 US9922115W WO0018365A2 WO 2000018365 A2 WO2000018365 A2 WO 2000018365A2 US 9922115 W US9922115 W US 9922115W WO 0018365 A2 WO0018365 A2 WO 0018365A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- film
- film according
- consumable
- consumable film
- pullulan
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/50—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by shape, structure or physical form, e.g. products with supported structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
- A61K8/21—Fluorides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A61K8/416—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/43—Guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/733—Alginic acid; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8129—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical; Compositions of hydrolysed polymers or esters of unsaturated alcohols with saturated carboxylic acids; Compositions of derivatives of such polymers, e.g. polyvinylmethylether
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
- A61K8/8176—Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
Definitions
- This invention relates to fast dissolving orally consumable films.
- the films are
- the films can also be used to deliver pharmaceutically active
- Oral cleansing can be difficult or inconvenient at times, depending on the
- compositions well-suited for the privacy of one's home are common oral care
- gums and lozenges have been formulated to
- gum is expressly banned from certain institutions, such as schools as well as
- Another portable oral cleansing product is a mouthspray. Like a mouthwash, a
- mouthspray can provide the consumer with a quick burst of strong breath-freshening
- mouthsprays are obtrusive. Spraying a mouthspray
- mouthsprays are typically packaged in relatively expensive and
- misdirecting the spray not only wastes the product, but can result in
- content products such as edible films, dentifrices and pharmaceuticals (column 3,
- the products can include a variety of ingredients in
- pullulan such as other polysaccharides, polyhydric alcohols, antiseptics
- products can include a variety of ingredients in addition to pullulan, such as other
- alcohol edible films which can comprise pullulan (column 3, line 59 to column 4, line
- the films are contrasted with existing pullulan-based films, which are said to
- molded article that can be a film made with pullulan.
- the articles contain a particular
- heteromannan which can be locust bean gum.
- Japanese Patent Document JP5-1198 discloses films made of polyvinyl alcohol
- WO 99/17753 discloses rapidly dissolving films for delivery of drugs to be
- WO 98/26780 discloses a flat, foil, paper or wafer type presentation for the
- ingredient disclosed in WO 98/26780 is buprenorphine.
- WO 98/20862 discloses a film for use in the oral cavity that can contain a
- WO 98/26763 discloses a flat, foil, paper or wafer like presentation for release
- the invention provides a physiologically acceptable film, which is particularly
- the film delivers at least one oral care agent, such as
- antimicrobial agents and salivary stimulants.
- the antimicrobial agents are effective
- stimulants are effective against the condition known as xerostomia or dry mouth.
- the oral care films are a breath freshener effective against oral malodor.
- the film former used to make the films according to the present invention entraps the
- oral care agents in the oral cavity to provide extended efficacy.
- the rapidly dissolvable film acts as a
- the invention is also directed to a method for producing a supple, non-self-
- the method comprises mixing a
- Fig. 1 is a photograph of an agar plate spread with Streptococcus mutans
- Fig. 2 is a photograph of an agar plate spread with Streptococcus mutans
- the film can be an effective tool in the prevention and treatment of
- film preferably comprises pullulan, thymol, methyl salicylate, eucalyptol and menthol.
- the essential oils in a hydro alcoholic solution. Many bad breath bacteria live in
- solid dosage form containing low amounts of these antimicrobial ingredients.
- the preferred consumable film of the invention captures a significant portion
- a further aspect of this invention is that while the amounts of LISTERTNE®
- essential oils are relatively high for incorporation in a film, the film according to the
- present invention still delivers a lower total amount of essential oils per unit dose
- preferred film forming ingredient, pullulan forms a thin layer on the oral surfaces entrapping the small amount of essential oils which are capable of penetrating into the
- JP 5-236885 teaches that its film should contain flavor and extract in
- the film of the invention preferably has an oil content of at least
- oils and other ingredients in the film are wt% after the film formulation
- the amounts of the specific essential oils used in the film compositions can be any suitable essential oils used in the film compositions.
- thymol methyl salicylate and eucalyptol
- Menthol can be
- composition added from about 0.01 to about 15 wt % of the composition, preferably about 2.0 to
- the amounts added can be readily determined to those skilled in the art and can exceed these amounts as long as the total oil content does not create sticking or other
- the essential oils are combined in
- a non-self- adhering film according to the invention can be stored in contact with
- non-stick agent e.g., a plastic film, paper or other support
- the film-forming agent used in the films according to the present invention can be any film-forming agent used in the films according to the present invention.
- cellulose polyvinyl alcohol, sodium alginate, polyethylene glycol, xanthan gum,
- tragacanth gum guar gum, acacia gum, arabic gum, polyacrylic acid,
- methylmethacrylate copolymer carboxyvinyl polymer, amylose, high amylose starch,
- hydroxypropylated high amylose starch dextrin, pectin, chitin, chitosan, levan, elsinan, collagen, gelatin, zein. gluten, soy protein isolate, whey protein isolate, casein
- a preferred film former is pullulan, in amounts ranging from
- the film of the invention preferably comprises pullulan as a film- forming agent
- the essential oils as antimicrobial/flavoring agents can further comprise
- binding agents coloring agents, sweeteners, fragrances, and the like.
- humectant in the film so as to avoid producing an overly moist, self-adhering film.
- the film with a plasticizing agent other than
- glycerin which is also a humectant, and with a sweetener other than sorbitol, which is
- Sulfur precipitating agents that reduce oral malodor can also be added to the
- oral care films according to the present invention. These agents bind with, and
- Sulfur precipitating agents useful in the present invention include metal salts such as copper salts and zinc salts.
- Preferred salts include copper gluconate, zinc citrate and
- the amount of sulfur precipitating agent is from about 0.01 to about 2
- wt % preferably about .15 wt % to about 1.5 wt %, even more preferably about .25 wt
- Saliva stimulating agents can also be added to the oral care films according to
- Useful saliva stimulating agents are those disclosed in U.S.
- stimulating agents include food acids such as citric, lactic, malic, succinic, ascorbic,
- adipic, fumaric and tartaric acids are preferred food acids.
- Preferred food acids are citric, malic and ascorbic
- the amount of saliva stimulating agents in the film is from about 0.01 to about
- Preferred plasticizing agents include triacetin in amounts ranging from about 0
- agents include monoacetin and diacetin.
- Preferred cooling agents include monomenthyl succinate, in amounts ranging
- suitable cooling agents include WS3, WS23, Ultracool II and the like.
- Preferred surfactants include mono and diglycerides of fatty acids and
- polyoxyethylene sorbitol esters such as, Atmos 300 and Polysorbate 80.
- the surfactant can be added in amounts ranging from about 0.5 to about 15 wt %,
- Preferred stabilizing agents include xanthan gum, locust bean gum and
- carrageenan in amounts ranging from about 0 to about 10 wt %, preferably about 0.1
- stabilizing agents include guar gum and the
- Preferred emulsifying agents include triethanolamine stearate, quaternary
- ammonium compounds acacia, gelatin, lecithin, bentonite, veegum. and the like, in
- Preferred thickening agents include methylcellulose, carboxyl methylcellulose,
- Preferred binding agents include starch, in amounts ranging from about 0 to
- Suitable sweeteners that can be included are those well known in the art,
- Suitable sweeteners include, e.g.:
- A. water-soluble sweetening agents such as monosaccharides,
- disaccharides and polysaccharides such as xylose, ribose, glucose (dextrose), mannose,
- galactose fructose (levulose), sucrose (sugar), maltose, invert sugar (a mixture of fructose and glucose derived from sucrose), partially hydrolyzed starch, corn syrup
- water-soluble artificial sweeteners such as the soluble saccharin
- salts i.e., sodium or calcium saccharin salts, cyclamate salts, the sodium, ammonium
- dipeptide based sweeteners such as L-aspartic acid derived
- sweeteners such as L-aspartyl-L-phenylalanine methyl ester (aspartame) and materials
- esters of L-aspartyl-L-phenylglycerin and L-aspa ⁇ tyl-L-2,5,dihydrophenyl-glycine are esters of L-aspartyl-L-phenylglycerin and L-aspa ⁇ tyl-L-2,5,dihydrophenyl-glycine,
- L-aspartyl-2,5-dihydro- L-phenylalanine L-aspartyl-L-(l-cyclohexyen)-alanine, and
- water-soluble sweeteners such as a chlorinated derivative of ordinary sugar (sucrose),
- E. protein based sweeteners such as thaumatoccous danielli
- auxiliary sweetener In general, an effective amount of auxiliary sweetener is utilized to provide the
- this amount will vary with the sweetener selected. This amount will normally be 0.01 % to about 10 % by weight
- sweeteners described in category A above are usually used in amounts of about 0.01
- sweeteners in category A e.g., glycyrrhizin
- sweeteners in category A can be used in amounts set forth for
- sweeteners described in categories B-E are generally used in amounts of about
- sweeteners need not be added to films intended for non-oral
- flavorings that can be used include those known to the skilled artisan, such as
- flavorings may be chosen from synthetic flavor
- oils and flavoring aromatics, and/or oils, oleo resins and extracts derived from plants are oils and flavoring aromatics, and/or oils, oleo resins and extracts derived from plants,
- oils include: spearmint oil, cinnamon oil, peppermint oil, clove oil, bay oil, thyme oil,
- cedar leaf oil oil of nutmeg, oil of sage, and oil of bitter almonds. Also useful are
- artificial, natural or synthetic fruit flavors such as vanilla, chocolate, coffee, cocoa and
- citrus oil including lemon, orange, grape, lime and grapefruit and fruit essences
- used flavors include mints such as peppermint, artificial vanilla, cinnamon derivatives,
- aldehydes and esters including cinnamyl acetate, cinnamaldehyde, citral,
- any flavoring or food additive such as those described in
- acetaldehyde apple
- benzaldehyde cherry, almond
- citral i.e., alpha citral (lemon, lime); neral, i.e. beta
- citral lemon, lime
- decanal range, lemon
- ethyl vanillin vanilla, cream
- heliotropine i.e., piperonal (vanilla, cream); vanillin (vanilla, cream); alpha-amyl
- cinnamaldehyde spicy fruity flavors
- butyraldehyde butter, cheese
- butyraldehyde berry fruits
- hexenal i.e. trans-2 (berry fruits)
- tolyl aldehyde cherry
- the amount of flavoring employed is normally a matter of preference subject to
- the amount may be varied in order to obtain the result desired in the final product.
- compositions of this invention can also contain coloring agents or
- the coloring agents are used in amounts effective to produce the desired
- coloring agents useful in the present invention include pigments such as
- titanium dioxide which may be incorporated in amounts of up to about 5 wt %, and
- Colorants can also include natural food colors and
- FD&C Blue No. 2 which is the disodium salt of
- Green No. 3 comprises a
- triphenylmethane dye and is the monosodium salt of 4-[4-N-ethyl-p-sulfobenzylamino)
- the preferred embodiment of the oral care film composition according to the present invention contains the essential oils used in Listerine® mouthwash to provide
- the films are shaped and sized to be placed in the oral cavity.
- the film adheres to a surface in the mouth, usually the roof of the mouth or the
- the amount of thymol in a preferred formula according to the present invention, the amount of thymol
- eucalyptol in the film is about 70 times less than in the mouthwash.
- methyl salicylate in the film is about 46 times less than in the mouthwash.
- amount of menthol in the film is about 2.8 times less than in the mouthwash.
- the inventors have unexpectedly found that the film provides sustained
- test product was dispensed and subjects dissolved one or two breath
- the thirty minute single film use group showed a reduction in mean log
- composition against oral malodor causing bacteria and (2) significant in vivo bacterial
- the panelist received a film treatment, either a single or double film. Panelists placed the breath film on the left side of their tongue covering the tongue from
- the swab was placed in a tube of peptone.
- the film used in the in vivo germ kill tests was Example 19 as described in
- Figure 1 is a photograph of an agar plate spread with
- Streptococcus mutans ATCC # 25175, to which a piece of an essential oil pullulan film according to the present invention was added.
- Figure 2 is a photograph of an agar plate spread with Streptococcus mutans
- essential oil in the drop are 2.200% menthol, 0.186% eucalyptol, 0.186% methyl
- the final formulation is preferably
- the organic phase which includes surfactants, such as Polysorbate 80 and Atmos 300.
- the resulting formulation is cast on a suitable substrate and dried to form a
- the film is preferably air-dried or dried under warm air and cut to a desired
- the film can contain from about 0.1% to about 10
- wt % moisture preferably from about 3 % to about 8 wt % moisture, even more
- the film-forming phase can include pullulan and stabilizing agents such as
- xanthan gum locust bean gum and carrageenan. These ingredients are mixed and then
- the water is preferably
- the water is
- the aqueous phase can include ingredients such as coloring agent(s), copper
- the water is preferably deionized and the amount of water used is about 5 to about 80 wt % of the final gel mixture.
- the preferred method of producing films comprises
- ingredients of the formulation provide the electrolytes, which are dissolved in the
- sweeteners other than saccharin with copper gluconate combine sweeteners other than saccharin with copper gluconate.
- Suitable pharmaceutically active agents include, but are not
- antimicrobial agents such as triclosan, cetyl pyridium chloride,
- domiphen bromide domiphen bromide, quaternary ammonium salts, zinc compounds, sanguinarine,
- non-steroidal anti-inflammatory drugs such as aspirin
- acetaminophen ibuprofen, ketoprofen, diflunisal, fenoprofen calcium, naproxen,
- anti-tussives such as benzonatate, caramiphen edisylate, menthol,
- D. decongestants such as pseudoephedrine hydrochloride
- anti-histamines such as brompheniramine maleate
- promethazine hydrochloride pyrilamine maleate, tripelennamine citrate, triprolidine hydrochloride, acrivastine, loratadine, brompheniramine, dexbrompheniramine, and
- F. expectorants such as guaifenesin, ipecac, potassium iodide,
- H. H 2 -antagonists such as famotidine, ranitidine, and the like.
- I. proton pump inhibitors such as omeprazole, lansoprazole, and
- CNS stimulants such as caffeine, nicotine,
- methsuximide methsuximide, phensuximide, trimethadione, diazepam, benzodiazepines,
- M. antiparkinsonism drugs such as levodopa, amantadine and the
- N. narcotic-analgesics such as morphine, heroin, hydromorphone,
- metopon metopon, oxymorphone, levorphanol, codeine, hydrocodone, xycodone, nalorphine,
- naloxone naloxone
- naltrexone O. analgesic-antipyretics such as salycilates, phenylbutazone,
- methotrimeprazine haloperidol, clozapine, rese ⁇ ine, imipramine, tranylcypromine,
- the ingredients used to make the pharmaceutical containing films are similar to
- the films that deliver a pharmaceutical agent can also include a triglyceride.
- triglycerides examples include vegetable oils such as corn oil, sunflower oil, peanut
- a preferred triglyceride is
- the triglyceride is added to the film in amounts from about 0.1 wt % to
- the films that contain pharmaceutical agents also can include a preservative.
- the preservative is added in amounts from about 0.001 wt % to about 5 wt %,
- the pharmaceutical agent containing films can also include a polyethylene
- the molecular weight of the polyethylene oxide compound ranges
- a preferred polyethylene oxide compound is
- the polyethylene oxide compound is N-10 available from Union Carbide Co ⁇ oration.
- the polyethylene oxide compound is N-10 available from Union Carbide Co ⁇ oration.
- the pharmaceutical agent containing films can also include propylene glycol.
- the propylene glycol is added in amounts from about 1 wt % to about 20 wt %,
- the active ingredient used in the film can be coated to mask the taste of the
- the film-forming ingredients e.g., xanthan gum, locust bean gum,
- coloring agent(s), copper gluconate and sweetener are added to and dissolved in purified water to form preparation B.
- flavoring agent and the oils e.g., cooling agent, thymol, methyl
- preparation D salicylate, eucalyptol and menthol are mixed to form preparation D.
- Preparation F is poured on a mold and cast to form a film of a desired thickness
- the film is dried under warm air and cut to a desired dimension
- Examples 14-18 were prepared using a preferred method, which comprised the
- step A to form a hydrated polymer gel
- step C stir the hydrated polymer from step C at slow speed (about 50-
- step D and mix until uniform
- Example 1 produced a film according to the invention having a blue-green tint
- Examples 2-4 contain sorbitol, glycerin or both. These examples yielded
- Examples 7-9 were produced to determine the effect of Avicel® on germ
- Examples 10 - 15 varied the amounts of aspartame and menthol to alter the
- Example 16 was prepared by replacing the sorbitol replaced with maltitol,
- Example 17 is prepared in which pullulan is replaced with another film former
- Example 18 is prepared in which pullulan is partially replaced with another film
- Example 19 represents a film containing a salivary stimulant, citric acid.
- Example 20 represents a film containing a salivary stimulant, citric acid.
- Example 20 is the film composition used in the antimicrobial efficacy studies
- ingredient in the finished, dried film depends upon the amount of relative moisture
- the rapidly dissolving film contains a pharmaceutical
- Examples 21A-21E listed in Table 3, are medicament containing rapidly
- dissolvable oral film formulas The amounts in Table 3 are in milligrams.
- Table 4 summarizes additional films according to the present invention.
- Example 22 A was used to make films containing a) 7.5 mg of
- dextromethorphan hydrobromide b) 2.5 mg of tripolidine, c) 4.0 mg of
- Example 22B was used to make a film containing 10 mg of dextrometorphan
- Example 22C was used to make a film containing 10 mg of dextromethorphan
- Example 22D was used to make a film containing a) 10 mg of phenylepherine
- Example 22E was used to make a film containing 7.5 mg dextromethorphan
- Example 22F was used to make a film containing 20 mg of coated
- dextromethorphan hydrobromide to provide a 7.5 mg dose.
- Example 22G was used to make a film containing a) 7.5 mg dextromethorphan
- Example 22H was used to make a film containing 15 mg of dextromethorphan
- Example 221 was used to make a film containing 15 mg of dextromethorphan hydrobromide.
- Example 22A was made using the following procedure.
- step 3 Add the gum mixture to the mixture of step 1 and mix until dissolved.
- Examples 22B-22E were made using the following procedure.
- step 4 Add the gums to the mixture of step 2 and mix until dissolve.
- Examples 22F - 221 were made in the same manner as Examples 20B - 20E,
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Food Science & Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Oncology (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000571886A JP2002525306A (en) | 1998-09-25 | 1999-09-23 | Rapidly dissolving oral consumable film |
CA002339353A CA2339353C (en) | 1998-09-25 | 1999-09-23 | Fast dissolving orally consumable films |
AU60593/99A AU771862B2 (en) | 1998-09-25 | 1999-09-23 | Fast dissolving orally consumable films |
KR1020017003793A KR20010075347A (en) | 1998-09-25 | 1999-09-23 | Fast Dissolving Orally Consumable Films |
SI9930907T SI1115372T1 (en) | 1998-09-25 | 1999-09-23 | Fast dissolving orally consumable films |
BRPI9914064-0A BR9914064B1 (en) | 1998-09-25 | 1999-09-23 | rapidly dissolving consumable film orally. |
EP99969668A EP1115372B1 (en) | 1998-09-25 | 1999-09-23 | Fast dissolving orally consumable films |
EEP200100186A EE200100186A (en) | 1998-09-25 | 1999-09-23 | Fast dissolving oral film |
IL14191999A IL141919A0 (en) | 1998-09-25 | 1999-09-23 | Fast dissolving orally consumable films |
DE69931380T DE69931380T2 (en) | 1998-09-25 | 1999-09-23 | QUICKLY ORAL CONSUMABLE FILMS |
NO20011476A NO20011476D0 (en) | 1998-09-25 | 2001-03-22 | Fast dissolving orally consumable films |
HK02102078.9A HK1040619A1 (en) | 1998-09-25 | 2002-03-19 | Fast dissolving orally consumable films |
CY20061101029T CY1105213T1 (en) | 1998-09-25 | 2006-07-25 | ORALLY DISSOLVING CONSUMABLE FIBERS |
IL192633A IL192633A0 (en) | 1998-09-25 | 2008-07-03 | Fast dissolving orally consumable films |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10179898P | 1998-09-25 | 1998-09-25 | |
US60/101,798 | 1998-09-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000018365A2 true WO2000018365A2 (en) | 2000-04-06 |
WO2000018365A3 WO2000018365A3 (en) | 2000-11-16 |
Family
ID=22286467
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/022115 WO2000018365A2 (en) | 1998-09-25 | 1999-09-23 | Fast dissolving orally consumable films |
Country Status (29)
Country | Link |
---|---|
US (8) | US6596298B2 (en) |
EP (2) | EP1676557A3 (en) |
JP (1) | JP2002525306A (en) |
KR (1) | KR20010075347A (en) |
CN (2) | CN1321080A (en) |
AR (2) | AR020513A1 (en) |
AT (1) | ATE326203T1 (en) |
AU (1) | AU771862B2 (en) |
BR (2) | BR9917781B1 (en) |
CA (1) | CA2339353C (en) |
CO (2) | CO4940396A1 (en) |
CY (1) | CY1105213T1 (en) |
DE (1) | DE69931380T2 (en) |
DK (1) | DK1115372T3 (en) |
EE (1) | EE200100186A (en) |
ES (1) | ES2260961T3 (en) |
GT (2) | GT199900164A (en) |
HK (1) | HK1040619A1 (en) |
ID (1) | ID27740A (en) |
IL (2) | IL141919A0 (en) |
NO (1) | NO20011476D0 (en) |
PA (1) | PA8482401A1 (en) |
PE (1) | PE20000972A1 (en) |
PT (1) | PT1115372E (en) |
SI (1) | SI1115372T1 (en) |
TW (2) | TWI238067B (en) |
UY (1) | UY25728A1 (en) |
WO (1) | WO2000018365A2 (en) |
ZA (1) | ZA200101706B (en) |
Cited By (91)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002002085A2 (en) * | 2000-07-04 | 2002-01-10 | Lts Lohmann Therapie-Systeme Ag | Rapidly-decomposing administrable form for releasing active ingredients in the oral cavity or in bodily cavities |
WO2002045714A1 (en) * | 2000-12-04 | 2002-06-13 | The Procter & Gamble Company | Drug formulation having improved oral tolerability |
WO2002049578A1 (en) * | 2000-12-20 | 2002-06-27 | Henkel Kommanditgesellschaft Auf Aktien | Remineralising dental adhesive film |
US6419903B1 (en) * | 2001-08-20 | 2002-07-16 | Colgate Palmolive Company | Breath freshening film |
WO2002058469A1 (en) * | 2001-01-23 | 2002-08-01 | Van Beek, Ron | Pesticidal compounds and compositions |
WO2002066016A2 (en) * | 2001-02-19 | 2002-08-29 | Lts Lohmann Therapie-Systeme Ag | Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine |
EP1236466A1 (en) * | 2001-02-28 | 2002-09-04 | Efrat Biopolymers Ltd. | Absorbable solid compositions for topical treatment of oral mucosal disorders |
WO2003030881A1 (en) * | 2001-10-12 | 2003-04-17 | Kosmos Pharma | Glucan based film delivery systems |
WO2003054077A1 (en) * | 2001-12-11 | 2003-07-03 | Ceapro Inc. | Cereal beta glucan compositions, methods of preparation and uses thereof |
US6656493B2 (en) | 2001-07-30 | 2003-12-02 | Wm. Wrigley Jr. Company | Edible film formulations containing maltodextrin |
EP1370206A1 (en) * | 2001-01-09 | 2003-12-17 | Lavipharm Laboratories, Inc. | Devices for local and systemic delivery of active substances and methods of manufacturing thereof |
US6669929B1 (en) * | 2002-12-30 | 2003-12-30 | Colgate Palmolive Company | Dentifrice containing functional film flakes |
WO2004009050A1 (en) * | 2002-07-23 | 2004-01-29 | Colgate-Palmolive Company | Enzyme enhanced breath freshening film |
WO2004012720A1 (en) * | 2002-07-26 | 2004-02-12 | Pfizer Limited | Process for making orally consumable dosage forms |
WO2004024111A1 (en) * | 2002-09-16 | 2004-03-25 | Cp Kelco, U.S., Inc. | Pectin films |
EP1430896A1 (en) * | 2001-09-25 | 2004-06-23 | Kyukyu Pharmaceutical Co., Ltd. | Nicotine−containing film preparation |
WO2004052335A1 (en) * | 2002-12-06 | 2004-06-24 | Monosolrx Llc | Thin film delivery systems for volatile decongestants |
WO2004058231A2 (en) * | 2002-12-26 | 2004-07-15 | University Of Manitoba | Dissolving film comprising a therapeutically active agent within the film or in a pouch formed by the film |
WO2004066986A1 (en) * | 2003-01-30 | 2004-08-12 | Monosolrx Llc | Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
WO2004087089A2 (en) * | 2003-03-26 | 2004-10-14 | The Procter & Gamble Company | Rapidly dissolving edible film compositions with improved film strength and stability |
WO2004089336A2 (en) * | 2003-04-02 | 2004-10-21 | The Procter & Gamble Company | Drug delivery systems comprising an encapsulated active ingredient |
WO2004091528A2 (en) * | 2003-04-14 | 2004-10-28 | Fmc Corporation | Delivery systems of homogeneous thermoreversible alginate films |
WO2004105758A1 (en) * | 2003-05-30 | 2004-12-09 | The Boots Company Plc | Use of tripolidine in providing refreshedness on waking |
US6916463B2 (en) | 2002-09-24 | 2005-07-12 | The Procter & Gamble Company | Oral products having an aesthetic layer |
EP1560571A2 (en) * | 2002-11-14 | 2005-08-10 | Innozen, Inc. | Edible film for relief of cough or symptoms associated with pharyngitis |
WO2005082332A2 (en) * | 2004-02-20 | 2005-09-09 | National Starch And Chemical Investment Holding Corporation | Dissolvable film comprising an active ingredient and method of manufacture |
WO2005082048A2 (en) * | 2004-02-20 | 2005-09-09 | National Starch And Chemical Investment Holding Corporation | Dissolvable film and method of manufacture |
EP1648362A2 (en) * | 2003-07-01 | 2006-04-26 | Todd Maibach | Film comprising therapeutic agents |
US7041311B2 (en) | 2003-02-28 | 2006-05-09 | International Flavors & Fragrances Inc. | Preparation for saliva flow |
EP1656018A1 (en) * | 2003-08-22 | 2006-05-17 | Innozen, Inc. | Edible films for administration of medicaments to animals |
WO2006081617A1 (en) * | 2005-02-02 | 2006-08-10 | Novapharm Research (Australia) Pty Ltd | Biostatic polymer |
EP1790687A3 (en) * | 2001-12-11 | 2007-07-25 | Ceapro Inc. | Cereal beta glucan compositions, methods of preparation and uses thereof |
EP1674078A3 (en) * | 2000-03-23 | 2007-07-25 | Warner-Lambert Company LLC | Fast dissolving orally consumable filsm containing an ion exchange resin as a taste masking agent |
US7285520B2 (en) | 2003-12-01 | 2007-10-23 | Kimberly-Clark Worldwide, Inc. | Water disintegratable cleansing wipes |
WO2008028278A1 (en) * | 2006-09-05 | 2008-03-13 | University Of Manitoba | Antimicrobial coatings |
WO2008108940A1 (en) * | 2007-03-05 | 2008-09-12 | Mcneil-Ppc, Inc. | Fast-dissolving/disintegrating film preparation having high proportion of active |
WO2008137164A1 (en) * | 2007-05-07 | 2008-11-13 | Hwa-Song Liu | Edible thin film strips and process for making |
WO2009017708A2 (en) * | 2007-07-31 | 2009-02-05 | Bill Mcanalley | Compositions, uses, and method of making wound care products from naturally occurring food ingredients |
US7666396B2 (en) | 2003-09-11 | 2010-02-23 | Kimberly-Clark Worldwide, Inc. | Single-use moisturizing product |
US7897080B2 (en) | 2001-10-12 | 2011-03-01 | Monosol Rx, Llc | Polyethylene-oxide based films and drug delivery systems made therefrom |
US7910031B2 (en) | 2001-10-12 | 2011-03-22 | Monosol Rx, Llc | Process for forming an ingestible thin film with non-self-aggregating uniform heterogeneity |
CN101073407B (en) * | 2007-06-15 | 2011-04-20 | 广东富味制果厂有限公司 | Edible refreshing pearl and its production |
US7972618B2 (en) * | 2006-09-20 | 2011-07-05 | Monosol Rx, Llc | Edible water-soluble film containing a foam reducing flavoring agent |
US8062686B2 (en) | 2005-04-12 | 2011-11-22 | InovoBiologics, Inc. | Dietary supplement, and methods of use |
US8105625B2 (en) | 2007-04-05 | 2012-01-31 | University Of Kansas | Rapidly dissolving pharmaceutical compositions comprising pullulan |
US8106152B2 (en) | 2003-12-19 | 2012-01-31 | Dairy Australia Limited | Antimicrobial composition |
WO2012048816A1 (en) | 2010-10-15 | 2012-04-19 | Lts Lohmann Therapie-Systeme Ag | Laminate having improved water retention characteristics |
EP1713450A4 (en) * | 2004-01-30 | 2012-06-27 | Corium Int Inc | Rapidly dissolving film for delivery of an active agent |
US8273405B2 (en) | 2001-05-01 | 2012-09-25 | A.V. Topcheiv Institute of Petrochemical Synthesis, Russian Academy of Sciences | Water-absorbent adhesive compositions and associated methods of manufacture and use |
EP2422764A4 (en) * | 2009-04-23 | 2013-01-09 | Lotte Co Ltd | Composition for use in the oral cavity |
US8475832B2 (en) | 2009-08-07 | 2013-07-02 | Rb Pharmaceuticals Limited | Sublingual and buccal film compositions |
US8481071B2 (en) | 2001-05-01 | 2013-07-09 | Corium International, Inc. | Hydrogel compositions with an erodible backing member |
US8481059B2 (en) | 2001-05-01 | 2013-07-09 | A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Sciences | Hydrogel compositions |
US8541021B2 (en) | 2001-05-01 | 2013-09-24 | A.V. Topchiev Institute Of Petrochemical Synthesis | Hydrogel compositions demonstrating phase separation on contact with aqueous media |
US8597709B2 (en) | 2005-04-12 | 2013-12-03 | Inovobiologic Inc. | Dietary supplement and methods of use |
US8652378B1 (en) | 2001-10-12 | 2014-02-18 | Monosol Rx Llc | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
US8663687B2 (en) | 2001-10-12 | 2014-03-04 | Monosol Rx, Llc | Film compositions for delivery of actives |
US8685437B2 (en) | 2001-10-12 | 2014-04-01 | Monosol Rx, Llc | Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
DE102013000700A1 (en) * | 2012-10-04 | 2014-04-10 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Composition useful e.g. for treating inflammatory diseases of oral and pharyngeal cavity, comprises virustatic and/or antiviral polysaccharide, surface disinfectant, optionally acidic glycosaminoglycan and optionally local anesthetic |
US8765167B2 (en) | 2001-10-12 | 2014-07-01 | Monosol Rx, Llc | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
US8784879B2 (en) | 2009-01-14 | 2014-07-22 | Corium International, Inc. | Transdermal administration of tamsulosin |
US8821901B2 (en) | 2001-05-01 | 2014-09-02 | A.V. Topchiev Institute Of Petrochemical Synthesis Russian Academy Of Sciences | Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components |
US8840919B2 (en) | 2003-03-28 | 2014-09-23 | Cure Pharmaceutical Corporation | Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films |
US8840918B2 (en) | 2001-05-01 | 2014-09-23 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Hydrogel compositions for tooth whitening |
US8900497B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for making a film having a substantially uniform distribution of components |
US8900629B2 (en) | 2007-04-05 | 2014-12-02 | University Of Kansas | Rapidly dissolving pharmaceutical compositions comprising pullulan |
US8900498B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for manufacturing a resulting multi-layer pharmaceutical film |
US8968709B2 (en) | 2007-07-25 | 2015-03-03 | 3M Innovative Properties Company | Therapeutic dental composition and related methods |
US8974826B2 (en) | 2010-06-10 | 2015-03-10 | Monosol Rx, Llc | Nanoparticle film delivery systems |
US8980334B2 (en) | 2001-02-28 | 2015-03-17 | Axiomedic Ltd. | Double-layered absorbable solid compositions for the topical treatment of oral mucosal disorders |
EP1542903B1 (en) | 2002-07-22 | 2015-05-20 | MonoSolRX, LLC | Packaging and dispensing of rapid dissolve dosage form |
EP2187970A4 (en) * | 2007-08-10 | 2015-06-03 | Genic Co Ltd | Dissolvable nano web porous film and method of preparing the same |
US9108340B2 (en) | 2001-10-12 | 2015-08-18 | Monosol Rx, Llc | Process for manufacturing a resulting multi-layer pharmaceutical film |
USRE45666E1 (en) | 2000-07-07 | 2015-09-08 | A.V. Topchiev Institute Of Petrochemical Synthesis | Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties |
US9226515B2 (en) | 2004-02-03 | 2016-01-05 | Cargill, Incorporated | Protein concentrate and an aqueous stream containing water-soluble carbohydrates |
US9499419B2 (en) | 2004-09-27 | 2016-11-22 | Special Waters Patents B.V. | Methods and compositions for treatment of skin |
US9504857B2 (en) | 2010-01-29 | 2016-11-29 | Colgate-Palmolive Company | Oral care formulations for malodor control |
US10034833B2 (en) | 2009-08-07 | 2018-07-31 | Aquestive Therapeutics, Inc. | Sublingual and buccal film compositions |
DE102017112527A1 (en) | 2017-06-07 | 2018-12-13 | Lts Lohmann Therapie-Systeme Ag | Fast disintegrating foam wafers with a high basis weight |
US10272607B2 (en) | 2010-10-22 | 2019-04-30 | Aquestive Therapeutics, Inc. | Manufacturing of small film strips |
US10285910B2 (en) | 2001-10-12 | 2019-05-14 | Aquestive Therapeutics, Inc. | Sublingual and buccal film compositions |
DE102017127434A1 (en) | 2017-11-21 | 2019-05-23 | Lts Lohmann Therapie-Systeme Ag | Pocket-shaped oral-release films with high drug loading |
US10398644B2 (en) | 2002-11-14 | 2019-09-03 | Cure Pharmaceutical Corporation | Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films |
DE102019100483A1 (en) | 2019-01-10 | 2020-07-16 | Lts Lohmann Therapie-Systeme Ag | Oral thin film |
WO2021030247A1 (en) * | 2019-08-14 | 2021-02-18 | Intercontinental Great Brands Llc | Confectionery chip product; and methods of making the same |
US11077068B2 (en) | 2001-10-12 | 2021-08-03 | Aquestive Therapeutics, Inc. | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
EP3871693A1 (en) | 2005-09-27 | 2021-09-01 | Special Water Patents B.V. | Compositions for oral care |
US11191737B2 (en) | 2016-05-05 | 2021-12-07 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine compositions |
US11207805B2 (en) | 2001-10-12 | 2021-12-28 | Aquestive Therapeutics, Inc. | Process for manufacturing a resulting pharmaceutical film |
US11273131B2 (en) | 2016-05-05 | 2022-03-15 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
WO2022106923A1 (en) | 2020-11-18 | 2022-05-27 | BioPharma Synergies, S. L. | Orodispersible powder composition comprising an antihistamine compound |
Families Citing this family (429)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6596298B2 (en) * | 1998-09-25 | 2003-07-22 | Warner-Lambert Company | Fast dissolving orally comsumable films |
US20030206942A1 (en) | 1998-09-25 | 2003-11-06 | Neema Kulkarni | Fast dissolving orally consumable films containing an antitussive and a mucosa coating agent |
US20030211136A1 (en) * | 1998-09-25 | 2003-11-13 | Neema Kulkarni | Fast dissolving orally consumable films containing a sweetener |
CA2356533C (en) | 1998-12-23 | 2010-07-13 | Mount Sinai School Of Medicine | Inhibitors of the bitter taste response |
US20040115252A1 (en) * | 1999-06-25 | 2004-06-17 | Thomas Leon | Methods of treating illnesses in non-human mammals |
EP1200064B1 (en) | 1999-07-02 | 2003-05-02 | The Procter & Gamble Company | Delivery system for oral care compositions comprising organosiloxane reins using a removable backing strip |
CN1252154C (en) * | 1999-07-22 | 2006-04-19 | 沃纳-兰伯特公司 | Pullulan film compositions |
US7314716B2 (en) * | 1999-11-19 | 2008-01-01 | Mount Sinai School Of Medicine | Gustducin γ subunit materials and methods |
US6315987B1 (en) * | 2000-05-10 | 2001-11-13 | Isp Investments Inc. | Polymeric delivery and release systems for oral care actives |
US20060062864A1 (en) * | 2000-12-28 | 2006-03-23 | Mccleary Edward L | Weight loss composition and method |
US20040043013A1 (en) | 2000-12-28 | 2004-03-04 | Mccleary Edward Larry | Metabolic uncoupling therapy |
US20060110478A1 (en) * | 2004-11-22 | 2006-05-25 | Mccleary Edward L | Delivery system and method for supporting and promoting healthy sexual function and prevention and treatment of sexual dysfunction |
US20060014773A1 (en) * | 2001-04-19 | 2006-01-19 | Mccleary Edward L | Mental agility lozenge, edible strip, food or drink |
US6803420B2 (en) | 2001-05-01 | 2004-10-12 | Corium International | Two-phase, water-absorbent bioadhesive composition |
US6976647B2 (en) * | 2001-06-05 | 2005-12-20 | Elan Pharma International, Limited | System and method for milling materials |
US6660292B2 (en) * | 2001-06-19 | 2003-12-09 | Hf Flavoring Technology Llp | Rapidly disintegrating flavored film for precooked foods |
ES2344407T3 (en) * | 2001-10-09 | 2010-08-26 | Arrow Coated Products Limited | MANUFACTURING PROCEDURE OF A SOLUBLE FILM SYSTEM IN EMBEDDED WATER. |
US20070154527A1 (en) * | 2001-10-12 | 2007-07-05 | Monosoirx, Llc | Topical film compositions for delivery of actives |
US20100021526A1 (en) * | 2001-10-12 | 2010-01-28 | Monosol Rx, Llc | Ph modulated films for delivery of actives |
US7910641B2 (en) * | 2001-10-12 | 2011-03-22 | Monosol Rx, Llc | PH modulated films for delivery of actives |
US20060039958A1 (en) * | 2003-05-28 | 2006-02-23 | Monosolrx, Llc. | Multi-layer films having uniform content |
US20030099691A1 (en) * | 2001-11-16 | 2003-05-29 | Susan Lydzinski | Films containing starch |
GB0128674D0 (en) * | 2001-11-30 | 2002-01-23 | Boots Co Plc | Treatment of sleep disorders and the like |
KR20030054221A (en) * | 2001-12-24 | 2003-07-02 | 애경산업(주) | Composite film composition for oral cavity and preparing method thereof |
US20030224090A1 (en) * | 2002-02-11 | 2003-12-04 | Edizone, Lc | Snacks of orally soluble edible films |
US20050003048A1 (en) * | 2002-02-11 | 2005-01-06 | Edizone, Lc | Electrolyte-containing orally soluble films |
US20040247649A1 (en) * | 2002-02-11 | 2004-12-09 | Edizone, Lc | Medicine-containing orally soluble films |
US20050100640A1 (en) * | 2002-02-11 | 2005-05-12 | Pearce Tony M. | Microcapsule edibles |
US20040247744A1 (en) * | 2002-02-11 | 2004-12-09 | Edizone, Lc | Vitamin-containing orally soluble films |
US20040247746A1 (en) * | 2002-02-11 | 2004-12-09 | Edizone, Lc | Delivery units of thick orally soluble polymer |
US20030191029A1 (en) * | 2002-03-28 | 2003-10-09 | Elementis Specialties, Inc. | Aqueous-based oil well drilling fluids containing high amylose starch polymers |
CA2480403A1 (en) * | 2002-04-08 | 2003-10-23 | Lavipharm Laboratories Inc. | Drug-complex microparticles and methods of making/using same |
US8017150B2 (en) * | 2002-04-11 | 2011-09-13 | Monosol Rx, Llc | Polyethylene oxide-based films and drug delivery systems made therefrom |
EP1504765B1 (en) * | 2002-05-16 | 2015-07-22 | Kyukyu Pharmaceutical Co., Ltd. | Quickly soluble film preparations |
DE10224607B4 (en) * | 2002-06-04 | 2008-03-13 | Lts Lohmann Therapie-Systeme Ag | Film-form, disintegratable preparations for drug release and process for their preparation |
JP2004018470A (en) * | 2002-06-18 | 2004-01-22 | Takasago Internatl Corp | Antimicrobial perfume composition, foul breath-preventing perfume composition, and composition for oral cavity containing the compositions |
US20030235613A1 (en) * | 2002-06-19 | 2003-12-25 | Cts Chemical Industries Ltd. | Popping oral administration form |
US20030235630A1 (en) * | 2002-06-21 | 2003-12-25 | Nussen Kenneth H. | Dental hygiene products and methods of making dental hygiene products |
US20030235606A1 (en) * | 2002-06-21 | 2003-12-25 | Nussen Kenneth H. | Oral hygiene products and methods of making oral hygiene products |
US6937455B2 (en) * | 2002-07-03 | 2005-08-30 | Kronos Advanced Technologies, Inc. | Spark management method and device |
US20050287231A1 (en) * | 2002-06-21 | 2005-12-29 | Nussen Kenneth H | Method and apparatus for oral hygiene products with green tea extract |
US20050025719A1 (en) * | 2002-06-21 | 2005-02-03 | Nussen Kenneth H. | Method and apparatus for oral hygiene products with green tea extract |
CA2493839C (en) * | 2002-06-25 | 2012-11-20 | Wm. Wrigley Jr. Company | Breath freshening and oral cleansing product with magnolia bark extract |
US7595065B2 (en) * | 2002-06-25 | 2009-09-29 | Wm. Wrigley Jr. Company | Breath freshening and oral cleansing products with synergistic combinations of magnolia bark extract and essential oils |
US7632525B2 (en) * | 2002-06-25 | 2009-12-15 | Wm. Wrigley Jr. Company | Breath freshening and oral cleansing product with magnolia bark extract in combination with surface active agents |
CN1723011A (en) * | 2002-06-25 | 2006-01-18 | Wm·雷格利Jr·公司 | Breath freshening and oral cleansing product with magnolia bark extract |
US7150780B2 (en) * | 2004-01-08 | 2006-12-19 | Kronos Advanced Technology, Inc. | Electrostatic air cleaning device |
US20040013723A1 (en) * | 2002-07-16 | 2004-01-22 | PARIKH Rita M. | Oral care capsules |
AU2002950426A0 (en) * | 2002-07-29 | 2002-09-12 | Patrick John Shanahan | Anti microbial oro-dental system |
AU2003281744B2 (en) * | 2002-07-29 | 2005-03-10 | Patrick John Shanahan | Oral and dental composition |
US6824829B2 (en) * | 2002-08-23 | 2004-11-30 | Acupac Packaging, Inc. | Process for manufacturing thin film strips |
US7241411B2 (en) | 2002-08-23 | 2007-07-10 | Acupac Packaging, Inc. | Thin film strips |
WO2004019867A2 (en) * | 2002-08-27 | 2004-03-11 | Wm. Wrigley Jr. Company | Breath freshening and oral cleansing product using cardamom oil |
EP1545447A4 (en) * | 2002-08-27 | 2005-12-14 | Wrigley W M Jun Co | Breath freshening and oral cleansing product using salicylaldehyde |
US20040043134A1 (en) * | 2002-08-27 | 2004-03-04 | Corriveau Christine Leclair | Rolled edible thin film products and methods of making same |
AU2003260091A1 (en) * | 2002-08-27 | 2004-03-19 | Wm. Wrigley Jr. Company | Breath freshening and oral cleansing product using carvacrol |
GB2408686A (en) * | 2002-09-06 | 2005-06-08 | Mars Inc | Edible films having distinct regions |
US20040120991A1 (en) * | 2002-09-07 | 2004-06-24 | Mars Incorporated | Edible films having distinct regions |
US20050019277A1 (en) * | 2002-09-11 | 2005-01-27 | The Procter & Gamble Company | Tooth whitening products |
US8524200B2 (en) | 2002-09-11 | 2013-09-03 | The Procter & Gamble Company | Tooth whitening products |
ATE514418T1 (en) * | 2002-11-12 | 2011-07-15 | Elan Pharma Int Ltd | RAPIDLY DISRUPTING SOLID DOSAGE FORMS WITH NON-FRUABLE CONSISTENCY AND PULLULAN |
US8999372B2 (en) * | 2002-11-14 | 2015-04-07 | Cure Pharmaceutical Corporation | Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use |
US20040096569A1 (en) * | 2002-11-15 | 2004-05-20 | Barkalow David G. | Edible film products and methods of making same |
US20040115137A1 (en) * | 2002-12-17 | 2004-06-17 | Verrall Andrew P. | Water-soluble film for oral administration |
SE0302947D0 (en) * | 2003-01-24 | 2003-11-07 | Magle Ab | A composition material for transmucosal delivery |
US20040228892A1 (en) * | 2003-02-28 | 2004-11-18 | Berry Craig J. | Delivery system for cosmetic and skincare products |
AT414095B (en) * | 2003-03-11 | 2006-09-15 | Gebro Pharma Gmbh | Preparation useful e.g. to treat dry mucous membrane in oral and throat area comprises medical and/or food organic substance, flavor material, mucoadhesive substance, sugar (alcohol) and carrier substance e.g. fat and/or oil |
US20040180110A1 (en) * | 2003-03-14 | 2004-09-16 | Atul Mistry | Chewing gum and confectionery compositions containing an endothermic agent |
US20040185093A1 (en) * | 2003-03-18 | 2004-09-23 | Szymczak Christopher E. | Compositions containing sucralose |
WO2004087084A1 (en) * | 2003-03-26 | 2004-10-14 | The Procter & Gamble Company | Rapidly dissolving edible film compositions with cellulose film forming polymers |
US20040202755A1 (en) * | 2003-04-08 | 2004-10-14 | Myers Gale D. | Speckled confection pieces |
US6708826B1 (en) * | 2003-04-30 | 2004-03-23 | Warner-Lambert Company, Llc | Packaged supply of individual doses of a personal care product |
GB0312419D0 (en) * | 2003-05-30 | 2003-07-02 | Boots Healthcare Int Ltd | Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess |
DE10325140B4 (en) * | 2003-06-04 | 2014-12-31 | Lts Lohmann Therapie-Systeme Ag | Direct coating method and apparatus |
US8703209B2 (en) * | 2003-06-17 | 2014-04-22 | Edward Larry McCleary | Composition and method for modulating hydrogen ion physiology |
PL1648421T3 (en) * | 2003-07-24 | 2018-03-30 | Glaxosmithkline Llc | Orally dissolving films |
US20050069501A1 (en) * | 2003-08-15 | 2005-03-31 | Sayed Ibrahim | Rapid temporary tooth whitening composition |
US20050072443A1 (en) * | 2003-10-06 | 2005-04-07 | Kuchenbecker Lee Ann | Dental hygiene accessories |
US20050075432A1 (en) * | 2003-10-07 | 2005-04-07 | Verrall Andrew P. | Acidulent film and method of making same |
US20050079253A1 (en) * | 2003-10-10 | 2005-04-14 | Hiroshi Nakamura | Bilayer edible sheet |
US9248146B2 (en) * | 2003-10-24 | 2016-02-02 | Adhesives Research, Inc. | Dissolvable adhesive films for delivery of pharmaceutical or cosmetic agents |
EP1680079A4 (en) | 2003-10-24 | 2008-01-02 | Adhesives Res Inc | Rapidly disintegrating films for delivery of pharmaceutical or cosmetic agents |
NO320283B1 (en) * | 2003-10-30 | 2005-11-21 | Ntnu Technology Transfer As | Use of the plant Sphagnum, oral hygiene product and methods for controlling unwanted bacterial flora on teeth |
EP1679978B1 (en) * | 2003-11-03 | 2013-01-23 | Hill's Pet Nutrition, Inc. | Coated pet food composition |
US8627828B2 (en) | 2003-11-07 | 2014-01-14 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
CN104397869B (en) | 2003-11-07 | 2016-06-08 | 美国无烟烟草有限责任公司 | Tobacco compositions |
US7182964B2 (en) * | 2003-11-13 | 2007-02-27 | Dbc, Llc | Dissolving thin film xanthone supplement |
DE10354894A1 (en) * | 2003-11-24 | 2005-07-07 | Hf Arzneimittelforschung Gmbh | Oral formulations of deoxypeganine and their applications |
BRPI0417666B1 (en) | 2003-12-16 | 2015-10-20 | Colgate Palmolive Co | composition for oral or personal treatment. |
US20050136112A1 (en) * | 2003-12-19 | 2005-06-23 | Pediamed Pharmaceuticals, Inc. | Oral medicament delivery system |
US20050137262A1 (en) * | 2003-12-22 | 2005-06-23 | Hu Patrick C. | Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses |
DE102004002951A1 (en) * | 2004-01-21 | 2005-08-11 | Wella Ag | Process for producing hair-setting products in film form |
US20050196348A1 (en) * | 2004-03-03 | 2005-09-08 | Constantine Georgiades | Stabilized peroxide compositions |
US20070190125A1 (en) | 2004-03-03 | 2007-08-16 | Constantine Georgiades | Positioning feature for aiding use of film or strip product |
US20070269519A1 (en) * | 2004-03-03 | 2007-11-22 | Constantine Georgiades | Whitening products |
EP1732507A1 (en) * | 2004-03-03 | 2006-12-20 | Warner-Lambert Company LLC | Stabilized peroxide compositions |
US20050196355A1 (en) * | 2004-03-03 | 2005-09-08 | Constantine Georgiades | Film products having controlled disintegration properties |
US20050196354A1 (en) * | 2004-03-03 | 2005-09-08 | Andre Soshinsky | Film compositions |
US20050196497A1 (en) * | 2004-03-03 | 2005-09-08 | Kraft Foods Holdings, Inc. | Antimicrobial effect of chitosan in beverages |
US20080003248A1 (en) * | 2004-03-03 | 2008-01-03 | Constantine Georgiades | Whitening products |
US20050208108A1 (en) * | 2004-03-19 | 2005-09-22 | Jannusch Leonard C | Thermoplastic films and methods for making |
US20050226964A1 (en) * | 2004-04-07 | 2005-10-13 | Michael Small | Water soluble seal and cap |
US7785619B2 (en) * | 2004-04-08 | 2010-08-31 | Micro Nutrient, Llc | Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens |
WO2005097085A1 (en) * | 2004-04-08 | 2005-10-20 | Micro Nutrient, Llc | Nutrient system for individualized responsive dosing regimens |
US7850987B2 (en) * | 2004-04-08 | 2010-12-14 | Micronutrient, Llc | Nutrient composition(s) and system(s) for individualized, responsive dosing regimens |
US20050230871A1 (en) * | 2004-04-20 | 2005-10-20 | Bess William S | Fast-dissolving films |
EP1593376A1 (en) * | 2004-05-04 | 2005-11-09 | Warner-Lambert Company LLC | Improved pullulan capsules |
US7118732B2 (en) * | 2004-05-10 | 2006-10-10 | Colgate-Palmolive Company | Tooth-whitening compositions comprising silicone polymer and methods therefor |
CA2470463C (en) | 2004-06-09 | 2012-09-18 | Lornamead Brands, Inc. | Tooth whitening products and methods of making the same |
WO2005120455A1 (en) * | 2004-06-12 | 2005-12-22 | Passion For Life Healthcare Limited | Soluble strip for oral or topical administration |
US7281541B2 (en) * | 2004-06-16 | 2007-10-16 | Lorch Leonard G | Dental floss |
US20050281757A1 (en) * | 2004-06-17 | 2005-12-22 | Sayed Ibrahim | Oral care film |
US9267167B2 (en) * | 2004-06-28 | 2016-02-23 | Becton, Dickinson And Company | Dissolvable films and methods including the same |
US7334538B1 (en) * | 2004-07-27 | 2008-02-26 | Aquascience Research Group, Inc. | Topical medicants for aquatic animals |
US20060024425A1 (en) * | 2004-07-30 | 2006-02-02 | Wm. Wrigley Jr. Company | Edible film compositions |
WO2006013081A1 (en) * | 2004-08-02 | 2006-02-09 | Glaxo Group Limited | Novel composition for xerostomia |
CN103497713B (en) | 2004-08-05 | 2018-07-17 | 考里安国际公司 | Adhesive composition |
US7959902B1 (en) * | 2004-09-21 | 2011-06-14 | Postlewaite Laura M | Device and method for treating the oral cavity |
US20060062811A1 (en) * | 2004-09-21 | 2006-03-23 | Szymczak Christopher E | Medicinal cooling emulsions |
EP1806033A2 (en) * | 2004-09-30 | 2007-07-11 | Homaro R. Cantu | System and methods for preparing substitute food items |
US20060073190A1 (en) * | 2004-09-30 | 2006-04-06 | Carroll Thomas J | Sealed, edible film strip packets and methods of making and using them |
US20060104910A1 (en) * | 2004-11-15 | 2006-05-18 | Keith Lerner | Over dosage indicating medicated film strip |
US8758816B2 (en) * | 2004-11-24 | 2014-06-24 | Meda Pharmaceuticals Inc. | Compositions comprising azelastine and methods of use thereof |
PT2522365T (en) | 2004-11-24 | 2017-02-08 | Meda Pharmaceuticals Inc | Compositions comprising azelastine and methods of use thereof |
US20070020330A1 (en) | 2004-11-24 | 2007-01-25 | Medpointe Healthcare Inc. | Compositions comprising azelastine and methods of use thereof |
KR100701409B1 (en) * | 2004-11-26 | 2007-03-30 | 한국유나이티드제약 주식회사 | Pharmaceutical formulations containing sumatriptan succinate |
WO2006079056A1 (en) * | 2005-01-20 | 2006-07-27 | Stephen Holt | Herbal compositions containing hoodia |
US20070275135A1 (en) * | 2005-02-09 | 2007-11-29 | First Flavor, Inc. | Taste sampling process and product |
EP1848647B1 (en) | 2005-02-14 | 2011-03-30 | McNeil-PPC, Inc. | Package for a personal care product |
CA2603139A1 (en) * | 2005-03-04 | 2006-09-08 | Technologies Pharmaguild Inc. | Amine-based and imine-based polymers, uses and preparation thereof |
US20060207721A1 (en) * | 2005-03-17 | 2006-09-21 | Greg Slominski | Polymer adhesive splicing of water-soluble, orally ingestible thin film webs |
US7410532B2 (en) * | 2005-04-04 | 2008-08-12 | Krichtafovitch Igor A | Method of controlling a fluid flow |
AU2006242246A1 (en) * | 2005-05-03 | 2006-11-09 | Innozen, Inc. | Edible film for transmucosal delivery of nutritional supplements |
US20060254949A1 (en) * | 2005-05-12 | 2006-11-16 | Staggs William B Jr | Credit card-shaped drug delivery system |
US9023382B2 (en) * | 2005-06-08 | 2015-05-05 | Basf Corporation | Medicament carrier composition and method of forming a film therefrom |
US8975227B2 (en) | 2005-07-15 | 2015-03-10 | Emisphere Technologies, Inc. | Intraoral dosage forms of glucagon |
DK1917339T3 (en) * | 2005-08-18 | 2010-09-06 | Colgate Palmolive Co | Film with detergents |
US7861728B2 (en) * | 2006-02-10 | 2011-01-04 | R.J. Reynolds Tobacco Company | Smokeless tobacco composition having an outer and inner pouch |
US20070077300A1 (en) * | 2005-09-30 | 2007-04-05 | Wynn David W | Oral compositions containing a salivation inducing agent |
US20070098746A1 (en) | 2005-11-02 | 2007-05-03 | Nichols William M | Multi-layered coating technology for taste masking |
US7544377B2 (en) * | 2005-12-02 | 2009-06-09 | Gic Innovations Company | Chewable compositions with fast release magnolia bark extract |
CA2631501A1 (en) * | 2005-12-02 | 2007-06-07 | Gic Innovations Company | Confectionary compositions with magnolia bark extract |
US7592025B2 (en) * | 2005-12-02 | 2009-09-22 | Gic Innovations Company | Vehicles for oral care with magnolia bark extract |
US20070134297A1 (en) * | 2005-12-08 | 2007-06-14 | Naqam Washington | Device to aid in sexual pleasure |
US20070137668A1 (en) * | 2005-12-15 | 2007-06-21 | Borschke August J | Smoking articles and wrapping materials therefor |
US20070140992A1 (en) * | 2005-12-21 | 2007-06-21 | Lynn Schick | Taste masking of essential oils using a hydrocolloid |
US20070148213A1 (en) | 2005-12-22 | 2007-06-28 | Sayed Ibrahim | Film containing compositions |
EP1965774A2 (en) * | 2005-12-30 | 2008-09-10 | Cogentus Pharmaceuticals, Inc. | Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors |
JP2009523672A (en) * | 2006-01-20 | 2009-06-25 | モノソル アールエックス リミテッド ライアビリティ カンパニー | Packaging with film lining and its manufacturing method |
US7810507B2 (en) * | 2006-02-10 | 2010-10-12 | R. J. Reynolds Tobacco Company | Smokeless tobacco composition |
BRPI0708068A2 (en) * | 2006-02-17 | 2011-05-17 | Novartis Ag | collapsible buccal films |
WO2007100653A2 (en) * | 2006-02-23 | 2007-09-07 | E. I. Du Pont De Nemours And Company | Removable antimicrobial coating compositions and methods of use |
PT1998762E (en) * | 2006-03-16 | 2010-11-30 | Novartis Ag | Solid dosage form containing a taste masked active agent |
US20070218090A1 (en) * | 2006-03-17 | 2007-09-20 | Craig Berry | Dissolvable strip for delivery of an agent |
US20070231387A1 (en) * | 2006-04-04 | 2007-10-04 | Luigi Levi | Film-coated solid dosage forms |
WO2007115305A2 (en) | 2006-04-04 | 2007-10-11 | Cogentus Pharmaceuticals, Inc. | Oral dosage forms including an antiplatelet agent and an acid inhibitor |
US20070235349A1 (en) * | 2006-04-06 | 2007-10-11 | General Patent, Llc | Medicament Dispenser |
US20070235350A1 (en) * | 2006-04-06 | 2007-10-11 | John Warlick | Wallet Sized Medicament Dispenser |
WO2007127810A2 (en) * | 2006-04-25 | 2007-11-08 | Kronos Advanced Technologies, Inc. | Electrostatic loudspeaker and method of acoustic waves generation |
IL175338A0 (en) * | 2006-05-01 | 2006-09-05 | Biota Ltd | Orally administrable films and preparation thereof |
US8187659B2 (en) * | 2006-05-02 | 2012-05-29 | Jerry Robertson Real Estate Llc | Solid medicament dosage form consumption aid |
US7946296B2 (en) | 2006-05-26 | 2011-05-24 | Philip Morris Usa Inc. | Dissolvable tobacco film strips and method of making the same |
TW200817049A (en) * | 2006-06-05 | 2008-04-16 | Verus Pharmaceuticals Inc | Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms |
US20070293581A1 (en) * | 2006-06-05 | 2007-12-20 | Malcolm Hill | Methods for Buccal, Lingual or Sublingual Dosing Regimens of Epinephrine for the Treatment of Allergic Emergencies |
JP4859115B2 (en) * | 2006-06-07 | 2012-01-25 | 松谷化学工業株式会社 | Edible film for oral hygiene |
US20080152761A1 (en) * | 2006-12-20 | 2008-06-26 | Shiji Shen | Packaging of Food Products with Pullulan Films |
US20070292481A1 (en) * | 2006-06-16 | 2007-12-20 | Hoffman Andrew J | Packaging of Food Products with Pullulan Films |
US20070298078A1 (en) * | 2006-06-27 | 2007-12-27 | Harrison Michael D | Water Soluble Article for Imparting Dietary Fiber to Bottled Water |
US20080014228A1 (en) * | 2006-07-14 | 2008-01-17 | Olivia Darmuzey | Solid form |
KR20120065434A (en) * | 2006-07-14 | 2012-06-20 | 더 프록터 앤드 갬블 캄파니 | Treatment articles capable of delivering intensive care and overall treatment simultaneously |
US20080026062A1 (en) * | 2006-07-31 | 2008-01-31 | Isaac Farr | Pharmaceutical compositions including nano-sized active agent |
US20080026040A1 (en) * | 2006-07-31 | 2008-01-31 | Isaac Farr | Active agent-releasing dosage forms |
JP5014712B2 (en) * | 2006-09-06 | 2012-08-29 | ライオン株式会社 | Oral dissolution film |
WO2008042331A2 (en) * | 2006-09-29 | 2008-04-10 | Monosol Rx Llc | Film embedded packaging and method of making same |
HUE038022T4 (en) * | 2006-10-02 | 2023-02-28 | Spepharm Ag | Non-mucoadhesive film dosage forms |
WO2008046041A2 (en) * | 2006-10-13 | 2008-04-17 | Thomas Kalili | Dissolving strip for oral mucosa as a systemic drug delivery route |
DE102006061287A1 (en) * | 2006-12-22 | 2008-06-26 | Lts Lohmann Therapie-Systeme Ag | Edible foil-shaped preparation with cola flavor |
US20090198262A1 (en) * | 2006-12-26 | 2009-08-06 | Discus Dental, Llc | Disposable tongue scraper |
WO2008098195A2 (en) * | 2007-02-09 | 2008-08-14 | Todd Maibach | Film comprising nitroglycerin |
MX2009006114A (en) * | 2007-03-02 | 2009-11-10 | Meda Pharmaceuticals Inc | Compositions comprising carisoprodol and methods of use thereof. |
US8663659B2 (en) * | 2007-03-07 | 2014-03-04 | Novartis Ag | Orally administrable films |
US20090011115A1 (en) * | 2007-03-13 | 2009-01-08 | Foss Carter D | Edible Pullulan Films Containing Flavoring |
US8568777B2 (en) * | 2007-03-30 | 2013-10-29 | Monosol Rx, Llc | Packaged film dosage unit containing a complexate |
US20080274252A1 (en) * | 2007-04-12 | 2008-11-06 | Hoffman Andrew J | Pullulan film containing sweetener |
US20080260836A1 (en) * | 2007-04-18 | 2008-10-23 | Thomas James Boyd | Films Comprising a Plurality of Polymers |
US20080274187A1 (en) * | 2007-05-02 | 2008-11-06 | J.C. Bright M. Ltd. | Hard capsule composition and method of use |
US20080311162A1 (en) * | 2007-05-16 | 2008-12-18 | Olivia Darmuzey | Solid form |
US9125836B2 (en) * | 2007-06-07 | 2015-09-08 | Sato Pharmaceutical Co., Ltd. | Film preparation with rapidly dissolving property and flexibility |
US20090004254A1 (en) * | 2007-06-19 | 2009-01-01 | Todd Maibach | Film comprising active drugs |
WO2008157033A1 (en) | 2007-06-20 | 2008-12-24 | Mcneil-Ppc, Inc | Products for whitening teeth |
JP5101191B2 (en) * | 2007-06-29 | 2012-12-19 | リンテック株式会社 | Film-form preparation and method for producing the same |
WO2009005814A2 (en) * | 2007-07-03 | 2009-01-08 | Marchitto Kevin S | Drug-delivery patch comprising a dissolvable layer and uses thereof |
JP5339635B2 (en) | 2007-07-23 | 2013-11-13 | アール・ジエイ・レイノルズ・タバコ・カンパニー | Smokeless tobacco composition and method of treating tobacco for using the same |
US8323695B2 (en) | 2007-08-13 | 2012-12-04 | Mcneil-Ppc, Inc. | Method for stabilizing phenylephrine |
JP2009096803A (en) * | 2007-09-26 | 2009-05-07 | Showa Kako Kk | Oral cavity patch type slowly soluble preparation |
WO2009043588A2 (en) * | 2007-10-02 | 2009-04-09 | LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH | Ph regulating antibacterial films for the oral or vaginal cavity |
KR100905027B1 (en) * | 2007-10-03 | 2009-06-30 | (주)씨엘팜 | Edible Film |
US9125434B2 (en) | 2007-10-11 | 2015-09-08 | Philip Morris Products S.A. | Smokeless tobacco product, smokeless tobacco product in the form of a sheet, extrudable tobacco composition, method for manufacturing a smokeless tobacco product, method for delivering super bioavailable nicotine contained in tobacco to a user, and packaged smokeless tobacco product sheet |
MX2010003928A (en) | 2007-10-11 | 2010-09-10 | Philip Morris Prod | Smokeless tobacco product. |
US20090098192A1 (en) * | 2007-10-11 | 2009-04-16 | Fuisz Richard C | Extrudable and Extruded Compositions for Delivery of Bioactive Agents, Method of Making Same and Method of Using Same |
US20090142452A1 (en) * | 2007-11-19 | 2009-06-04 | Michael David Campbell | Dissolvable Orally Consumable Flavored Sensual Enhancement Films |
US20090253754A1 (en) * | 2007-12-04 | 2009-10-08 | Francesca Selmin | Fast dissolving films and coatings for controlled release of flavors, active pharmaceutical ingredients, food substances, and nicotine |
US20090162516A1 (en) * | 2007-12-21 | 2009-06-25 | Brown Solomon E | Edible, water-soluble film |
WO2009082437A2 (en) | 2007-12-21 | 2009-07-02 | Ligand Pharmaceuticals Incorporated | Selective androgen receptor modulators (sarms) and uses thereof |
CA2956278C (en) * | 2008-01-04 | 2022-03-01 | Schabar Research Associates Llc | Unit oral dose compositions composed of ibuprofen and famotidine and applications thereof |
WO2009099830A2 (en) * | 2008-01-31 | 2009-08-13 | Mcneil-Ppc, Inc. | Edible film-strips for immediate release of active ingredients |
WO2009099831A2 (en) * | 2008-01-31 | 2009-08-13 | Mcneil-Ppc, Inc. | Edible film-strips with modified release active ingredients |
US8497409B2 (en) | 2008-02-29 | 2013-07-30 | Kimberly-Clark Worldwide, Inc. | Absorbent article having an olfactory wetness signal |
WO2009148442A1 (en) | 2008-06-04 | 2009-12-10 | Colgate-Palmolive Company | Oral care implement with cavitation system |
GB2462022B (en) | 2008-06-16 | 2011-05-25 | Biovascular Inc | Controlled release compositions of agents that reduce circulating levels of platelets and methods thereof |
KR101866189B1 (en) * | 2008-08-25 | 2018-06-11 | 규큐 야쿠힝 고교 가부시키가이샤 | Film preparation containing loperamide hydrochloride |
US8715715B2 (en) * | 2008-11-03 | 2014-05-06 | Nal Pharmaceuticals Ltd. | Dosage form for insertion into the mouth |
US20100178254A1 (en) * | 2009-01-13 | 2010-07-15 | Monosol Rx Llc | Unit assembly for multiple film dosages, apparatus, and methods |
US20100183717A1 (en) | 2009-01-16 | 2010-07-22 | Kristin Arnold | Controlled-release formulations |
US20100209484A1 (en) * | 2009-02-13 | 2010-08-19 | Hoo-Kyun Choi | Transdermal Triptan Delivery System |
WO2010103384A1 (en) * | 2009-03-13 | 2010-09-16 | Nucitec S.A. De C.V. | Compositions and methods for treatment and prevention of cardiovascular disease |
EP2233134A1 (en) | 2009-03-27 | 2010-09-29 | McNeil AB | Multi-portion intra-oral dosage form with organoleptic properties |
US20100256197A1 (en) * | 2009-04-02 | 2010-10-07 | Silver Eagle Labs Nv, Llc | Nicotine Dissolving Film With Or Without Menthol |
US20100256215A1 (en) * | 2009-04-02 | 2010-10-07 | Silver Eagle Labs Nv, Llc | Menthol-Melatonin Dissolving Film |
WO2010138492A2 (en) | 2009-05-26 | 2010-12-02 | Colgate-Palmolive Company | Dentifrice composition |
CN105411869A (en) * | 2009-05-26 | 2016-03-23 | 高露洁-棕榄公司 | Dentifrice Composition |
TWI396554B (en) | 2009-05-26 | 2013-05-21 | Colgate Palmolive Co | Oral care formulations that enhance amount of soluble zinc |
WO2010150930A1 (en) * | 2009-06-25 | 2010-12-29 | (주)벡스코아 | Fast dissolving film for oral administration which prevents unpleasant taste effectively |
US20110177146A1 (en) * | 2009-07-27 | 2011-07-21 | E. I. Du Pont De Nemours And Company | Removable antimicrobial coating compositions containing cationic rheology agent and methods of use |
US20110027199A1 (en) * | 2009-07-30 | 2011-02-03 | Danny Frye | Drink container with a breath strip |
BR112012002152A2 (en) * | 2009-07-30 | 2016-06-07 | Procter & Gamble | oral care article |
TR200907338A1 (en) * | 2009-09-28 | 2011-04-21 | Yedi̇tepe Üni̇versi̇tesi̇ | A film strip containing natural ingredients. |
DK3403654T3 (en) | 2009-10-01 | 2019-08-26 | Adare Dev I L P | ORAL ADMINISTRATED CORTIC COSTEROIDS COMPOSITIONS |
US8357398B2 (en) * | 2009-10-21 | 2013-01-22 | Alitair Pharmaceuticals Inc. | Benzonatate compositions and methods of use |
US8701671B2 (en) | 2011-02-04 | 2014-04-22 | Joseph E. Kovarik | Non-surgical method and system for reducing snoring |
US9549842B2 (en) | 2011-02-04 | 2017-01-24 | Joseph E. Kovarik | Buccal bioadhesive strip and method of treating snoring and sleep apnea |
RU2554807C2 (en) | 2009-12-04 | 2015-06-27 | Колгейт-Палмолив Компани | Dissolvable films containing high concentrations of non-ionic surfactants such as polysorbates to enhance high solid loadings |
US20110136815A1 (en) | 2009-12-08 | 2011-06-09 | Horst Zerbe | Solid oral film dosage forms and methods for making same |
US10610528B2 (en) | 2009-12-08 | 2020-04-07 | Intelgenx Corp. | Solid oral film dosage forms and methods for making same |
US20130011462A1 (en) | 2009-12-30 | 2013-01-10 | Novartis Ag | Melt extruded nicotine thin strips |
EP2519224A1 (en) | 2009-12-30 | 2012-11-07 | Novartis AG | Melt extruded thin strips containing coated pharmaceutical actives |
TWI458497B (en) | 2010-01-13 | 2014-11-01 | Colgate Palmolive Co | Stabilization of zinc oxide film in oral compositions |
US8397945B2 (en) | 2010-02-23 | 2013-03-19 | R.J. Reynolds Tobacco Company | Dispensing container |
EP2543366B1 (en) * | 2010-03-03 | 2018-10-24 | Kyukyu Pharmaceutical Co., Ltd. | Film preparation containing medicament with unpleasant taste |
DE102010014869A1 (en) * | 2010-04-13 | 2011-10-13 | Lts Lohmann Therapie-Systeme Ag | Hydrogel for natural cosmetic purposes |
US20110268809A1 (en) | 2010-04-28 | 2011-11-03 | Paul Andrew Brinkley | Nicotine-Containing Pharmaceutical Compositions |
US20110274628A1 (en) | 2010-05-07 | 2011-11-10 | Borschke August J | Nicotine-containing pharmaceutical compositions |
US8232238B2 (en) * | 2010-06-03 | 2012-07-31 | The Clorox Company | Concentrated film delivery systems |
CA2799713A1 (en) | 2010-06-23 | 2011-12-29 | Colgate-Palmolive Company | Encapsulation of ingredients in lactose matrix to form active encapsulates |
BR112012030192A2 (en) | 2010-06-30 | 2016-09-20 | Colgate Palmolive Co | multi-layer film flavor release during brushing |
MX344033B (en) | 2010-06-30 | 2016-12-01 | Colgate-Palmolive Company * | Multilayer films for delivery of flavor. |
CA2803377C (en) | 2010-07-02 | 2018-03-20 | The Procter & Gamble Company | Methods of delivering a health care active by administering personal health care articles comprising a filament |
CN103003476B (en) | 2010-07-02 | 2016-02-10 | 宝洁公司 | Web material and the method for the manufacture of web material |
BR112012033600A2 (en) | 2010-07-02 | 2016-11-29 | Procter & Gamble Comapny | filaments comprising ingestible nonwoven webs and methods of manufacturing them. |
WO2012003367A2 (en) | 2010-07-02 | 2012-01-05 | The Procter & Gamble Company | Method for delivering an active agent |
JP5859526B2 (en) | 2010-07-02 | 2016-02-10 | ザ プロクター アンド ギャンブルカンパニー | Filaments containing an activator nonwoven web and methods for making the same |
RU2543892C2 (en) | 2010-07-02 | 2015-03-10 | Дзе Проктер Энд Гэмбл Компани | Production of films from nonwoven webs |
US10028520B2 (en) | 2010-09-02 | 2018-07-24 | R.J. Reynolds Tobacco Company | Apparatus for manufacturing a smokeless tobacco product incorporating an object, and associated method |
US10238684B2 (en) | 2010-11-18 | 2019-03-26 | Foundational Biosystems, Llc | Micro- and nano-quantity sleep enhancing nutrient composition and method of enhancing central nervous system protein clearance using same |
US9648874B2 (en) * | 2010-12-07 | 2017-05-16 | Kimberly-Clark Worldwide, Inc. | Natural, multiple use and re-use, user saturated wipes |
AU2010365038B2 (en) | 2010-12-07 | 2015-08-20 | Colgate-Palmolive Company | Oral and personal care compositions comprising zinc containing films |
SG190974A1 (en) | 2010-12-23 | 2013-07-31 | Colgate Palmolive Co | Aqueous oral care composition comprising xanthan gum, cellulose gum and carbomer |
JP2014501258A (en) | 2010-12-23 | 2014-01-20 | コルゲート・パーモリブ・カンパニー | Fluid composition comprising a structuring agent |
PT2663294E (en) | 2011-01-11 | 2016-01-25 | Capsugel Belgium Nv | New hard capsules comprising pullulan |
US9277976B2 (en) | 2011-01-24 | 2016-03-08 | Leonard G. Lorch | Dental floss |
US9277977B2 (en) | 2011-01-24 | 2016-03-08 | Leonard G. Lorch | Dental floss |
US8381742B2 (en) | 2011-01-24 | 2013-02-26 | Leonard G. Lorch | Dental floss |
US10206765B2 (en) | 2011-01-24 | 2019-02-19 | Leonard G. Lorch | Dental floss |
US11951139B2 (en) | 2015-11-30 | 2024-04-09 | Seed Health, Inc. | Method and system for reducing the likelihood of osteoporosis |
US11844720B2 (en) | 2011-02-04 | 2023-12-19 | Seed Health, Inc. | Method and system to reduce the likelihood of dental caries and halitosis |
US10085938B2 (en) | 2011-02-04 | 2018-10-02 | Joseph E. Kovarik | Method and system for preventing sore throat in humans |
US11951140B2 (en) | 2011-02-04 | 2024-04-09 | Seed Health, Inc. | Modulation of an individual's gut microbiome to address osteoporosis and bone disease |
US11357722B2 (en) | 2011-02-04 | 2022-06-14 | Seed Health, Inc. | Method and system for preventing sore throat in humans |
CA2834231A1 (en) | 2011-04-28 | 2012-11-01 | Acme Specialty Products, Llc | Taste masking compositions and edible forms thereof |
KR101303479B1 (en) * | 2011-07-28 | 2013-09-06 | (주)씨엘팜 | Composition for edible film and pharmaceutical preparation for edible film containing drugs |
JP5496287B2 (en) * | 2011-09-15 | 2014-05-21 | ローム アンド ハース カンパニー | Low gloss aqueous coating composition containing poly (ethylene oxide) for use in leather |
JP5781037B2 (en) * | 2011-09-15 | 2015-09-16 | ローム アンド ハース カンパニーRohm And Haas Company | Low gloss aqueous coating composition comprising poly (ethylene oxide) |
US20130078307A1 (en) | 2011-09-22 | 2013-03-28 | Niconovum Usa, Inc. | Nicotine-containing pharmaceutical composition |
US9474303B2 (en) | 2011-09-22 | 2016-10-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US9084439B2 (en) | 2011-09-22 | 2015-07-21 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US9629392B2 (en) | 2011-09-22 | 2017-04-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
AU2012315782B2 (en) | 2011-09-30 | 2015-10-29 | Perio Sciences, Llc | Antioxidant compositions for treatment of inflammation or oxidative damage |
US9907748B2 (en) | 2011-10-21 | 2018-03-06 | Niconovum Usa, Inc. | Excipients for nicotine-containing therapeutic compositions |
RU2609862C2 (en) | 2011-12-15 | 2017-02-06 | Колгейт-Палмолив Компани | Aqueous oral care composition |
US8574628B2 (en) * | 2011-12-19 | 2013-11-05 | Kimberly-Clark Worldwide, Inc. | Natural, multiple release and re-use compositions |
US9763928B2 (en) | 2012-02-10 | 2017-09-19 | Niconovum Usa, Inc. | Multi-layer nicotine-containing pharmaceutical composition |
US9420825B2 (en) | 2012-02-13 | 2016-08-23 | R.J. Reynolds Tobacco Company | Whitened tobacco composition |
JP6050031B2 (en) * | 2012-06-01 | 2016-12-21 | 森下仁丹株式会社 | Film formulation |
CN104470378A (en) * | 2012-06-28 | 2015-03-25 | 奥普蒂迈格斯齐默尔曼博士有限公司 | Method for producing a film formulation for an edible film, and the use thereof |
EP2874824A1 (en) | 2012-07-23 | 2015-05-27 | Crayola LLC | Dissolvable films and methods of using the same |
CN102836144A (en) * | 2012-09-28 | 2012-12-26 | 天津市聚星康华医药科技有限公司 | Deoxidized epinephrine oral instant film and preparation method thereof |
CN104812378B (en) * | 2012-10-11 | 2017-12-01 | Ix生物制药有限公司 | Solid dosage forms |
CN102871984B (en) * | 2012-11-05 | 2015-11-11 | 天津市聚星康华医药科技有限公司 | A kind of Phenylephrine hydrochloride oral instant membrane and preparation method thereof |
US8859005B2 (en) | 2012-12-03 | 2014-10-14 | Intercontinental Great Brands Llc | Enteric delivery of functional ingredients suitable for hot comestible applications |
US20150342899A1 (en) * | 2012-12-28 | 2015-12-03 | Noven Pharmaceuticals, Inc. | Compositions and methods for transdermal delivery of amphetamine and clonidine |
WO2014116770A1 (en) | 2013-01-23 | 2014-07-31 | Arx, Llc | Production of unit dose constructs |
US8940675B2 (en) | 2013-01-31 | 2015-01-27 | The Procter & Gamble Company | Cleansing composition and a wet wipe comprising the same |
US20140255452A1 (en) | 2013-03-11 | 2014-09-11 | Niconovum Usa, Inc. | Method and apparatus for differentiating oral pouch products |
US9420827B2 (en) * | 2013-03-14 | 2016-08-23 | Altria Client Services Llc | Soft oral product |
WO2014145699A1 (en) | 2013-03-15 | 2014-09-18 | New Jersey Institute Of Technology | System and method for fabrication of uniform polymer films containing nano and micro particles via continuous drying process |
US9278050B2 (en) | 2013-04-01 | 2016-03-08 | Trevor Anderson | Dissolvable medication administration bag and method of using the same |
PH12014000076A1 (en) | 2013-07-01 | 2015-09-07 | Priscila F Kimes | Improved processes in the preparation of coconut meat based composition and films |
TW201503831A (en) * | 2013-07-11 | 2015-02-01 | Agrofresh Inc | Humidity activated formulation for volatile compounds |
TW201536214A (en) | 2013-07-16 | 2015-10-01 | Colgate Palmolive Co | System and method for making an oral care formulation |
WO2015034678A2 (en) | 2013-09-06 | 2015-03-12 | Aptalis Pharmatech, Inc. | Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis |
US11503853B2 (en) | 2013-09-09 | 2022-11-22 | R.J. Reynolds Tobacco Company | Smokeless tobacco composition incorporating a botanical material |
US10357054B2 (en) | 2013-10-16 | 2019-07-23 | R.J. Reynolds Tobacco Company | Smokeless tobacco pastille |
WO2015068058A1 (en) | 2013-11-06 | 2015-05-14 | Rk Technology & Investments Pte. Ltd. | Tobacco free 'niconuts'and the process thereof |
WO2015066819A1 (en) | 2013-11-08 | 2015-05-14 | Carlos Filipe | Method of stabilizing molecules without refrigeration using water soluble polymers and applications thereof in performing chemical reactions |
US9668970B2 (en) | 2013-12-02 | 2017-06-06 | Intelgenx Corp. | Film dosage form with extended release mucoadhesive particles |
US11033493B2 (en) | 2013-12-02 | 2021-06-15 | Intelgenx Corp. | Film dosage form with extended release mucoadhesive particles |
US10272038B2 (en) | 2013-12-02 | 2019-04-30 | Intelgenx Corp. | Film dosage form with extended release mucoadhesive particles |
US11839632B2 (en) | 2013-12-20 | 2023-12-12 | Seed Health, Inc. | Topical application of CRISPR-modified bacteria to treat acne vulgaris |
US11826388B2 (en) | 2013-12-20 | 2023-11-28 | Seed Health, Inc. | Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation |
US11833177B2 (en) | 2013-12-20 | 2023-12-05 | Seed Health, Inc. | Probiotic to enhance an individual's skin microbiome |
WO2015108988A2 (en) | 2014-01-17 | 2015-07-23 | Ligand Pharmaceuticals, Inc. | Methods and compositions for modulating hormone levels |
US9392814B2 (en) | 2014-06-06 | 2016-07-19 | Nicholas J. Singer | Delivery system for drinks |
US20160044955A1 (en) * | 2014-08-13 | 2016-02-18 | R.J. Reynolds Tobacco Company | Smokeless tobacco products |
US10959456B2 (en) | 2014-09-12 | 2021-03-30 | R.J. Reynolds Tobacco Company | Nonwoven pouch comprising heat sealable binder fiber |
FR3029103B1 (en) | 2014-11-27 | 2018-02-16 | Societe Industrielle Limousine D'application Biologique | SOLUBLE ADHESIVE DRESSING BASED ON MINERALS |
US20160157515A1 (en) | 2014-12-05 | 2016-06-09 | R.J. Reynolds Tobacco Company | Smokeless tobacco pouch |
EP3229778A1 (en) | 2014-12-09 | 2017-10-18 | MonoSol Rx LLC | Linear polysaccharide based film products |
US9956323B2 (en) | 2014-12-18 | 2018-05-01 | Cook Medical Technologies Llc | Medical devices for local bioactive delivery |
EP3061501A1 (en) | 2015-02-27 | 2016-08-31 | Rottapharm Ltd. | Composition for the treatment of acne |
US20160339086A1 (en) * | 2015-05-19 | 2016-11-24 | Suzy Cohen | Compositions and methods for treating thyroid disease |
USD773313S1 (en) | 2015-06-23 | 2016-12-06 | Nicholas J. Singer | Package |
EP3117825A1 (en) | 2015-07-16 | 2017-01-18 | Rottapharm S.p.A. | Oral formulation comprising berberine and morus alba extract |
US10342646B2 (en) * | 2015-10-17 | 2019-07-09 | James D. Welch | Method of, and system for smoothing teeth |
US11103732B1 (en) * | 2015-10-17 | 2021-08-31 | James D. Welch | Method of improving the condition of teeth |
US10532046B2 (en) | 2015-12-03 | 2020-01-14 | Niconovum Usa, Inc. | Multi-phase delivery compositions and products incorporating such compositions |
US20170165252A1 (en) | 2015-12-10 | 2017-06-15 | Niconovum Usa Inc. | Protein-enriched therapeutic composition |
US10499684B2 (en) | 2016-01-28 | 2019-12-10 | R.J. Reynolds Tobacco Company | Tobacco-derived flavorants |
US11154087B2 (en) | 2016-02-02 | 2021-10-26 | R.J. Reynolds Tobacco Company | Method for preparing flavorful compounds isolated from black liquor and products incorporating the flavorful compounds |
US10702590B2 (en) | 2016-04-12 | 2020-07-07 | Script Essentials, Llc | Compositions and methods for treating thyroid disease |
EP3766488A1 (en) | 2016-04-12 | 2021-01-20 | Schaneville, Scott | Ingestible films having substances from hemp or cannabis |
JP2018000402A (en) * | 2016-06-30 | 2018-01-11 | 静岡県 | Tongue cover |
MX2019000219A (en) * | 2016-07-05 | 2019-09-04 | Glaxosmithkline Consumer Healthcare Holdings Us Llc | Oral dosage form containing a fast release exterior coating. |
WO2018022516A1 (en) * | 2016-07-25 | 2018-02-01 | Olyxir, Llc | Olive leaf powder (olp) strips |
TWI777515B (en) | 2016-08-18 | 2022-09-11 | 美商愛戴爾製藥股份有限公司 | Methods of treating eosinophilic esophagitis |
AU2017359973B2 (en) | 2016-11-15 | 2023-02-16 | Klaria Pharma Holding Ab | Pharmaceutical formulation |
US9579292B1 (en) | 2016-11-21 | 2017-02-28 | Karl Wei Cao | Film forming hard capsule solution |
US9700518B1 (en) | 2016-11-21 | 2017-07-11 | Karl Wei Cao | Dip molding process for the manufacture of hard capsule shells |
US10806681B2 (en) * | 2017-01-09 | 2020-10-20 | The Procter & Gamble Company | Barrier patch with soluble film and methods of improving skin appearance |
JP6893650B2 (en) * | 2017-02-24 | 2021-06-23 | 学校法人福岡大学 | Release-controlled film containing water-soluble polysaccharides as the main component |
US11091446B2 (en) | 2017-03-24 | 2021-08-17 | R.J. Reynolds Tobacco Company | Methods of selectively forming substituted pyrazines |
US10470487B2 (en) | 2017-04-06 | 2019-11-12 | R.J. Reynolds Tobacco Company | Smoke treatment |
AU2018251256B2 (en) | 2017-04-14 | 2023-10-05 | Capsugel Belgium Nv | Pullulan capsules |
JP7222911B2 (en) | 2017-04-14 | 2023-02-15 | カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップ | How to make pullulan |
GB201709141D0 (en) | 2017-06-08 | 2017-07-26 | Klaria Pharma Holding Ab | Pharmaceutical formulation |
JP6837700B2 (en) | 2017-09-08 | 2021-03-03 | インシグニス セラピュティクス, インコーポレイテッドInsignis Therapeutics, Inc. | How to use dipivefrine |
CN111372555A (en) | 2017-11-21 | 2020-07-03 | 3M创新有限公司 | Water-in-bag plant-based oil emulsion for oral cavity and use method thereof |
JP7341143B2 (en) | 2017-12-20 | 2023-09-08 | スリーエム イノベイティブ プロパティズ カンパニー | Oral composition and method of use |
WO2019123261A2 (en) | 2017-12-20 | 2019-06-27 | 3M Innovative Properties Company | Oral compositions and methods of use |
KR20200085891A (en) | 2018-01-26 | 2020-07-15 | 더 프록터 앤드 갬블 캄파니 | Water soluble unit dose article containing fragrance |
WO2019147532A1 (en) | 2018-01-26 | 2019-08-01 | The Procter & Gamble Company | Water-soluble unit dose articles comprising perfume |
KR20200086739A (en) | 2018-01-26 | 2020-07-17 | 더 프록터 앤드 갬블 캄파니 | Water soluble unit dose article containing enzyme |
KR102433420B1 (en) | 2018-01-26 | 2022-08-18 | 더 프록터 앤드 갬블 캄파니 | Water-Soluble Articles and Related Methods |
WO2019168829A1 (en) | 2018-02-27 | 2019-09-06 | The Procter & Gamble Company | A consumer product comprising a flat package containing unit dose articles |
WO2019239356A1 (en) | 2018-06-15 | 2019-12-19 | R. J. Reynolds Tobacco Company | Purification of nicotine |
GB2575625A (en) | 2018-06-22 | 2020-01-22 | Church & Dwight Co Inc | Oral care compositions comprising benzocaine and mucoadhesive thin films formed therefrom |
WO2020010173A1 (en) * | 2018-07-06 | 2020-01-09 | Kansas State University Research Foundation | Lipid nanoemulsion-doped antimicrobial packaging films |
US10982176B2 (en) | 2018-07-27 | 2021-04-20 | The Procter & Gamble Company | Process of laundering fabrics using a water-soluble unit dose article |
US20200196658A1 (en) | 2018-12-20 | 2020-06-25 | R.J. Reynolds Tobacco Company | Method for whitening tobacco |
US11859338B2 (en) | 2019-01-28 | 2024-01-02 | The Procter & Gamble Company | Recyclable, renewable, or biodegradable package |
WO2020180608A1 (en) | 2019-03-01 | 2020-09-10 | Insignis Therapeutics, Inc. | Dipivefrin orally disintegrating tablet formulations |
EP3712237A1 (en) | 2019-03-19 | 2020-09-23 | The Procter & Gamble Company | Fibrous water-soluble unit dose articles comprising water-soluble fibrous structures |
KR20200117411A (en) * | 2019-04-04 | 2020-10-14 | (주)지웰바이오 | Antibacterial Composition for Inhibiting Oral Bacteria and orally disintegrating film |
US11213062B2 (en) | 2019-05-09 | 2022-01-04 | American Snuff Company | Stabilizer for moist snuff |
JP7381613B2 (en) | 2019-06-28 | 2023-11-15 | ザ プロクター アンド ギャンブル カンパニー | Dissolvable solid fibrous article containing anionic surfactant |
MX2022003094A (en) | 2019-09-11 | 2022-04-11 | Nicoventures Trading Ltd | Alternative methods for whitening tobacco. |
US20210068446A1 (en) | 2019-09-11 | 2021-03-11 | R. J. Reynolds Tobacco Company | Oral product with cellulosic flavor stabilizer |
US20210068448A1 (en) | 2019-09-11 | 2021-03-11 | Nicoventures Trading Limited | Method for whitening tobacco |
US20210068447A1 (en) | 2019-09-11 | 2021-03-11 | R. J. Reynolds Tobacco Company | Pouched products with enhanced flavor stability |
US11369131B2 (en) | 2019-09-13 | 2022-06-28 | Nicoventures Trading Limited | Method for whitening tobacco |
MX2022005285A (en) | 2019-10-31 | 2022-05-24 | Nicoventures Trading Ltd | Oral product and method of manufacture. |
US11617744B2 (en) | 2019-12-09 | 2023-04-04 | Nico Ventures Trading Limited | Moist oral compositions |
US11826462B2 (en) | 2019-12-09 | 2023-11-28 | Nicoventures Trading Limited | Oral product with sustained flavor release |
US11872231B2 (en) | 2019-12-09 | 2024-01-16 | Nicoventures Trading Limited | Moist oral product comprising an active ingredient |
WO2021116842A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral products with controlled release |
US20210169890A1 (en) | 2019-12-09 | 2021-06-10 | Nicoventures Trading Limited | Oral composition with polymeric component |
WO2021116856A2 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral products |
US20210169786A1 (en) | 2019-12-09 | 2021-06-10 | Nicoventures Trading Limited | Oral composition with beet material |
WO2021116823A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral product |
WO2021116919A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Fleece for oral product with releasable component |
WO2021116895A2 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Stimulus-responsive pouch |
WO2021116834A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Nanoemulsion for oral use |
US20210169123A1 (en) | 2019-12-09 | 2021-06-10 | Nicoventures Trading Limited | Pouched products with enhanced flavor stability |
WO2021116824A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral product comprising a cannabinoid |
JP2023505352A (en) | 2019-12-09 | 2023-02-08 | ニコベンチャーズ トレーディング リミテッド | Method |
US11793230B2 (en) | 2019-12-09 | 2023-10-24 | Nicoventures Trading Limited | Oral products with improved binding of active ingredients |
WO2021116825A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral product |
US20210169868A1 (en) | 2019-12-09 | 2021-06-10 | Nicoventures Trading Limited | Oral compositions with reduced water content |
US11672862B2 (en) | 2019-12-09 | 2023-06-13 | Nicoventures Trading Limited | Oral products with reduced irritation |
MX2022006980A (en) | 2019-12-09 | 2022-08-25 | Nicoventures Trading Ltd | Pouched products with heat sealable binder. |
US20210170031A1 (en) | 2019-12-09 | 2021-06-10 | Nicoventures Trading Limited | Oral composition with nanocrystalline cellulose |
US20210169138A1 (en) | 2019-12-09 | 2021-06-10 | Nicoventures Trading Limited | Fibrous fleece material |
US20210169132A1 (en) | 2019-12-09 | 2021-06-10 | Nicoventures Trading Limited | Oral composition including gels |
WO2021116826A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral product comprising a cannabinoid |
US20210169783A1 (en) | 2019-12-09 | 2021-06-10 | Nicoventures Trading Limited | Oral products with controlled release |
US11883527B2 (en) * | 2019-12-09 | 2024-01-30 | Nicoventures Trading Limited | Oral composition and method of manufacture |
US20210169785A1 (en) | 2019-12-09 | 2021-06-10 | Nicoventures Trading Limited | Oral compositions with reduced water activity |
US20210169126A1 (en) | 2019-12-09 | 2021-06-10 | Nicoventures Trading Limited | Oral composition with salt inclusion |
CA3159459A1 (en) | 2019-12-09 | 2021-06-17 | Savannah JOHNSON | Layered fleece for pouched product |
WO2021116916A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral product with multiple flavors having different release profiles |
WO2021116852A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral product with dissolvable component |
WO2021116881A1 (en) | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral product in a pourous pouch comprising a fleece material |
US20210169784A1 (en) | 2019-12-09 | 2021-06-10 | Nicoventures Trading Limited | Buffered oral compositions |
US11712059B2 (en) | 2020-02-24 | 2023-08-01 | Nicoventures Trading Limited | Beaded tobacco material and related method of manufacture |
WO2021250516A1 (en) | 2020-06-08 | 2021-12-16 | Nicoventures Trading Limited | Effervescent oral composition comprising an active ingredient |
IL299448A (en) | 2020-06-17 | 2023-02-01 | Psilo Scient Ltd | Process for Obtaining a Purified Psychoactive Alkaloid Solution |
US11324727B2 (en) | 2020-07-15 | 2022-05-10 | Schabar Research Associates, Llc | Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn |
CN116194102A (en) | 2020-07-15 | 2023-05-30 | 沙巴研究联合有限责任公司 | Unit oral dosage composition comprising ibuprofen and famotidine for treating acute pain and reducing the severity and/or risk of heartburn |
MX2023001042A (en) | 2020-07-31 | 2023-02-16 | Procter & Gamble | Water-soluble fibrous pouch containing prills for hair care. |
GB202013491D0 (en) | 2020-08-27 | 2020-10-14 | Nicoventures Holdings Ltd | Oral Product |
US11937626B2 (en) | 2020-09-04 | 2024-03-26 | Nicoventures Trading Limited | Method for whitening tobacco |
CN112076165B (en) * | 2020-09-08 | 2022-05-13 | 北京哈三联科技有限责任公司 | Orally disintegrating tablet capable of freshening breath and preparation method thereof |
US20240008522A1 (en) | 2020-11-18 | 2024-01-11 | Nicoventures Trading Limited | Oral products |
CA3197443A1 (en) | 2020-12-28 | 2022-06-28 | Psilo Scientific Ltd. | Processes for extracting psychoactive alkaloids and preparation thereof into transmucosal forms |
WO2022162558A1 (en) | 2021-01-28 | 2022-08-04 | Nicoventures Trading Limited | Method for sealing pouches |
JP2024516807A (en) | 2021-04-22 | 2024-04-17 | ニコベンチャーズ トレーディング リミテッド | Dissolving film in the mouth |
EP4329522A1 (en) | 2021-04-30 | 2024-03-06 | Nicoventures Trading Limited | Oral products with high-density load |
US20220354155A1 (en) | 2021-04-30 | 2022-11-10 | Nicoventures Trading Limited | Multi-compartment oral pouched product |
AU2022268733A1 (en) | 2021-05-06 | 2023-12-21 | Nicoventures Trading Limited | Oral compositions and related methods for reducing throat irritation |
EP4355121A1 (en) | 2021-06-16 | 2024-04-24 | Nicoventures Trading Limited | Pouched product comprising dissolvable composition |
WO2022269556A1 (en) | 2021-06-25 | 2022-12-29 | Nicoventures Trading Limited | Oral products and method of manufacture |
CA3233375A1 (en) | 2021-09-30 | 2023-04-06 | Michael Zawadzki | Oral product with a basic amine and an ion pairing agent |
FR3128880A1 (en) * | 2021-11-10 | 2023-05-12 | Strand Cosmetics Europe | WATER SOLUBLE FILM FOR TOPICAL APPLICATION |
US20230148660A1 (en) | 2021-11-15 | 2023-05-18 | Nicoventures Trading Limited | Products with enhanced sensory characteristics |
US20230148652A1 (en) | 2021-11-15 | 2023-05-18 | Nicoventures Trading Limited | Oral products with nicotine-polymer complex |
US20230309603A1 (en) | 2022-03-31 | 2023-10-05 | R.J. Reynolds Tobacco Company | Agglomerated botanical material for oral products |
WO2023194959A1 (en) | 2022-04-06 | 2023-10-12 | Nicoventures Trading Limited | Pouched products with heat sealable binder |
WO2023222213A1 (en) | 2022-05-18 | 2023-11-23 | Symrise Ag | Antimicrobial mixtures |
WO2023248187A1 (en) | 2022-06-24 | 2023-12-28 | Nicoventures Trading Limited | Oral composition comprising a receptor modulator |
WO2024079722A1 (en) | 2022-10-14 | 2024-04-18 | Nicoventures Trading Limited | Capsule-containing pouched products |
Citations (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3803300A (en) * | 1970-03-18 | 1974-04-09 | H Pospischil | Ointment foil and method of preparing the same |
EP0161681A2 (en) * | 1984-05-17 | 1985-11-21 | Mitsubishi Acetate Co., Ltd. | Gel plate and process for preparing same |
US4562020A (en) * | 1982-12-11 | 1985-12-31 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Process for producing self-supporting glucan film |
US4623394A (en) * | 1984-04-14 | 1986-11-18 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Gradually disintegrable molded article |
JPS6272609A (en) * | 1985-09-26 | 1987-04-03 | Sunstar Inc | Bathing agent |
JPS62135417A (en) * | 1985-12-09 | 1987-06-18 | Sato Seiyaku Kk | Filmy pharmaceutical |
EP0256611A1 (en) * | 1986-08-08 | 1988-02-24 | Squibb Japan Inc. | Oral drug delivery systems |
JPS63310818A (en) * | 1987-06-12 | 1988-12-19 | Sato Seiyaku Kk | Sheet preparation to be applied to oral mucosa |
US5023082A (en) * | 1986-05-18 | 1991-06-11 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Sustained-release pharmaceutical compositions |
EP0471558A2 (en) * | 1990-08-14 | 1992-02-19 | Unilever Plc | Moisture barrier and its preparation |
JPH04321619A (en) * | 1991-02-27 | 1992-11-11 | Nisshin Oil Mills Ltd:The | Composition for bath |
WO1993003649A1 (en) * | 1991-08-23 | 1993-03-04 | Gillette Canada Inc. | Sustained-release martrices for dental application |
EP0750905A2 (en) * | 1995-06-27 | 1997-01-02 | Kao Corporation | Patch comprising water soluble adhesive sheet |
US5629003A (en) * | 1990-06-07 | 1997-05-13 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Rapidly disintegrating sheet-like presentations of multiple dosage units |
EP0781546A1 (en) * | 1995-12-26 | 1997-07-02 | Sanwa Kagaku Kenkyusho Co., Ltd. | A multi-layered film preparation |
WO1997031621A1 (en) * | 1996-02-29 | 1997-09-04 | Warner-Lambert Company | Delivery system for localized administration of medicaments to the upper respiratory tract |
EP0803243A2 (en) * | 1996-04-24 | 1997-10-29 | Pfizer Inc. | Cyclodextrins and phenolic compounds in dental products |
US5700478A (en) * | 1993-08-19 | 1997-12-23 | Cygnus, Inc. | Water-soluble pressure-sensitive mucoadhesive and devices provided therewith for emplacement in a mucosa-lined body cavity |
US5741510A (en) * | 1994-03-30 | 1998-04-21 | Lectec Corporation | Adhesive patch for applying analgesic medication to the skin |
WO1998020862A1 (en) * | 1996-11-11 | 1998-05-22 | Lts Lohmann Therapie-Systeme Gmbh | Immediate wettability water soluble film or water soluble layer for oral application |
Family Cites Families (75)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1142325A (en) | 1965-05-14 | 1969-02-05 | Higham Stanley Russell | Means for administering drugs |
US3492131A (en) | 1966-04-18 | 1970-01-27 | Searle & Co | Peptide sweetening agents |
US3784390A (en) | 1971-07-23 | 1974-01-08 | Hayashibara Biochem Lab | Shaped bodies of pullulan and their use |
US4197289A (en) | 1975-12-15 | 1980-04-08 | Hoffmann-La Roche Inc. | Novel dosage forms |
JPS59111817A (en) * | 1982-12-11 | 1984-06-28 | Hayashibara Biochem Lab Inc | Manufacture of pullulan self-supporting film |
US4795436A (en) | 1983-11-14 | 1989-01-03 | Bio-Mimetics, Inc. | Bioadhesive composition and method of treatment therewith |
US4843098A (en) * | 1985-02-05 | 1989-06-27 | Warner-Lambert Company | Ingestible aggregate and delivery system prepared therefrom |
DE3532860C1 (en) * | 1985-09-14 | 1987-03-12 | Blendax Werke Schneider Co | Oral hygiene products |
CA1313620C (en) | 1986-08-08 | 1993-02-16 | Yasunobu Okada | Oral drug delivery systems |
JPS6359855A (en) | 1986-08-29 | 1988-03-15 | Jun Kawai | Edible film |
DE3630603A1 (en) | 1986-09-09 | 1988-03-10 | Desitin Arzneimittel Gmbh | PHARMACEUTICAL AND DOSAGE FORM FOR MEDICINAL ACTIVE SUBSTANCES, REAGENTS OR THE LIKE, AND METHOD FOR THE PRODUCTION THEREOF |
JPH0739508B2 (en) | 1986-11-11 | 1995-05-01 | 株式会社林原生物化学研究所 | Pullulan / polyethylene glycol aggregate, its production method and use |
US4923394A (en) * | 1986-11-19 | 1990-05-08 | Nippon Tansan Gas Co., Ltd. | Portable torch |
US4851394A (en) | 1986-12-30 | 1989-07-25 | Uni Colloid Kabushiki Kaisha | Glucomannan/polyhydric alcohol composition and film prepared therefrom |
JPS63250318A (en) | 1987-04-06 | 1988-10-18 | Fujimoto Seiyaku Kk | Pharmaceutical preparation suitable in oral cavity |
JPS63250319A (en) | 1987-04-06 | 1988-10-18 | Fujimoto Seiyaku Kk | Pharmaceutical preparation suitable in oral cavity |
US4820506A (en) | 1987-05-01 | 1989-04-11 | Research Foundation, State University Of New York | Salivary stimulant |
JPS63280014A (en) | 1987-05-12 | 1988-11-17 | Sekisui Chem Co Ltd | Plaster composition for bad breath prevention |
JPS63296655A (en) | 1987-05-29 | 1988-12-02 | Toppan Printing Co Ltd | Production of edible sheet |
US4975426A (en) | 1987-06-08 | 1990-12-04 | Analgesic Associates | Cough/cold mixtures comprising non-sedating antihistamine drugs |
JP2642354B2 (en) | 1987-06-11 | 1997-08-20 | 株式会社 三和化学研究所 | Manufacturing method of sustained release buccal |
JPH01160455A (en) | 1987-12-17 | 1989-06-23 | Yoshikawa Kikai Seisakusho:Kk | Feeding method of lump-like cake material and device therefor |
CN1036967A (en) * | 1988-02-04 | 1989-11-08 | 武田药品工业株式会社 | Edible film |
US5047244A (en) | 1988-06-03 | 1991-09-10 | Watson Laboratories, Inc. | Mucoadhesive carrier for delivery of therapeutical agent |
DE3827561C1 (en) * | 1988-08-13 | 1989-12-28 | Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De | |
JPH0259513A (en) * | 1988-08-24 | 1990-02-28 | Kiyuukiyuu Yakuhin Kogyo Kk | Oral cavity mucosa-attaching type halitosis-preventing agent |
US5089307A (en) * | 1989-05-23 | 1992-02-18 | Mitsubishi Rayon Co., Ltd. | Edible film and method of making same |
US5354551A (en) | 1989-10-14 | 1994-10-11 | Desitin Arzneimittel Gmbh | Oral and dental hygiene preparation |
US5284659A (en) * | 1990-03-30 | 1994-02-08 | Cherukuri Subraman R | Encapsulated flavor with bioadhesive character in pressed mints and confections |
JPH04117242A (en) * | 1990-09-05 | 1992-04-17 | Fuji Oil Co Ltd | Production of nonfusible film |
US5185153A (en) * | 1990-10-04 | 1993-02-09 | The Research Foundation Of The State University Of New York | Agents effecting the lysis of oral bacteria |
TW209174B (en) * | 1991-04-19 | 1993-07-11 | Takeda Pharm Industry Co Ltd | |
JPH051198A (en) | 1991-06-26 | 1993-01-08 | Japan Happy:Kk | Water-soluble film |
US5141961A (en) | 1991-06-27 | 1992-08-25 | Richrdson-Vicks Inc. | Process for solubilizing difficulty soluble pharmaceutical actives |
JPH05236885A (en) | 1991-07-17 | 1993-09-17 | Tazawa Toshihiko | Flavoring and refreshing food formed into film |
JPH0541602A (en) | 1991-08-06 | 1993-02-19 | Fujitsu General Ltd | Primary radiator in common use with circularly polarized wave and linearly polarized wave |
US5188822A (en) * | 1991-08-07 | 1993-02-23 | Chesebrough-Pond's Usa Co., Division Of Conopco Inc. | Oral compositions containing an aminosilicone and a lipophilic compound |
US5580578A (en) * | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
JP3232488B2 (en) | 1992-08-20 | 2001-11-26 | 株式会社林原生物化学研究所 | High content of pullulan, its production method and use |
US5286502A (en) * | 1992-04-21 | 1994-02-15 | Wm. Wrigley Jr. Company | Use of edible film to prolong chewing gum shelf life |
US5411945A (en) | 1992-08-29 | 1995-05-02 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Pullulan binder and its uses |
JP3313244B2 (en) * | 1994-08-11 | 2002-08-12 | 三井化学株式会社 | Salicylate resin and method for producing the same |
US5529783A (en) | 1994-12-19 | 1996-06-25 | Mcneil-Ppc, Inc. | Rotor granulation and coating of acetaminophen, pseudoephedrine, chlorpheniramine, and, optionally dextromethorphan |
US5641512A (en) | 1995-03-29 | 1997-06-24 | The Procter & Gamble Company | Soft gelatin capsule compositions |
WO1996039116A1 (en) | 1995-06-05 | 1996-12-12 | Whitehill Oral Technologies, Inc. | Oral care ultramulsion based products |
JPH09124512A (en) | 1995-10-26 | 1997-05-13 | Res Inst For Prod Dev | Water-soluble medicine-pullulan combination preparation for targeting liver |
US6348187B1 (en) * | 1996-01-24 | 2002-02-19 | Warner-Lambert Company | Peroxide/essential oils containing mouthwash compositions and two-part mouthwash systems |
EP0922464B1 (en) * | 1996-07-12 | 2005-03-30 | Daiichi Pharmaceutical Co., Ltd. | Quickly disintegrable compression-molded materials and process for producing the same |
AU4428397A (en) * | 1996-09-20 | 1998-04-14 | Warner-Lambert Company | Oral compositions containing a zinc compound |
DE19652188C2 (en) | 1996-12-16 | 2002-02-14 | Lohmann Therapie Syst Lts | Flat drug preparation for application and release of buprenorphine or a pharmacologically comparable substance in the oral cavity and process for its preparation |
DE19652268C2 (en) | 1996-12-16 | 2000-06-29 | Lohmann Therapie Syst Lts | Medicinal preparation for the release of apomorphine in the oral cavity |
JPH10179451A (en) | 1996-12-20 | 1998-07-07 | Aisin Seiki Co Ltd | Raising and lowering device for toilet seat with hot water washing device |
JPH10179045A (en) | 1996-12-25 | 1998-07-07 | Osaka Kagaku Gokin Kk | Sheet-like edible molding |
US5885594A (en) * | 1997-03-27 | 1999-03-23 | The Procter & Gamble Company | Oral compositions having enhanced mouth-feel |
US6136297A (en) | 1997-06-06 | 2000-10-24 | The Procter & Gamble Company | Delivery system for an oral care substance using a strip of material having low flexural stiffness |
JPH1160455A (en) * | 1997-06-13 | 1999-03-02 | Yuusuke Nonomura | Controlling agent for bacterial flora including preventing agent for dental caries and controlling |
GB2328443B (en) * | 1997-08-21 | 2001-09-05 | Reckitt & Colmann Prod Ltd | In situ formation of pharmaceutically acceptable polymeric material |
JP3460538B2 (en) * | 1997-10-08 | 2003-10-27 | 救急薬品工業株式会社 | Fast dissolving film preparation |
CA2300205A1 (en) * | 1997-12-22 | 1999-07-01 | Warner-Lambert Company | Compositions for inhibiting gingivitis |
US6432442B1 (en) * | 1998-02-23 | 2002-08-13 | Mcneil-Ppc, Inc. | Chewable product |
US6132702A (en) * | 1998-02-27 | 2000-10-17 | The Procter & Gamble Company | Oral care compositions comprising chlorite and methods |
US6596298B2 (en) * | 1998-09-25 | 2003-07-22 | Warner-Lambert Company | Fast dissolving orally comsumable films |
US20030211136A1 (en) * | 1998-09-25 | 2003-11-13 | Neema Kulkarni | Fast dissolving orally consumable films containing a sweetener |
US6231957B1 (en) * | 1999-05-06 | 2001-05-15 | Horst G. Zerbe | Rapidly disintegrating flavor wafer for flavor enrichment |
US7067116B1 (en) * | 2000-03-23 | 2006-06-27 | Warner-Lambert Company Llc | Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1 |
US6372252B1 (en) * | 2000-04-28 | 2002-04-16 | Adams Laboratories, Inc. | Guaifenesin sustained release formulation and tablets |
US20020131990A1 (en) | 2000-11-30 | 2002-09-19 | Barkalow David G. | Pullulan free edible film compositions and methods of making the same |
US6656493B2 (en) | 2001-07-30 | 2003-12-02 | Wm. Wrigley Jr. Company | Edible film formulations containing maltodextrin |
CA2457086A1 (en) | 2001-08-17 | 2003-02-27 | Smithkline Beecham P.L.C. | Oral care substance delivery strip |
US6419903B1 (en) | 2001-08-20 | 2002-07-16 | Colgate Palmolive Company | Breath freshening film |
DK2332523T4 (en) | 2001-10-12 | 2022-02-21 | Aquestive Therapeutics Inc | Uniform films for rapid-dissolution dosage form containing taste-masking preparations |
AU2002348432B2 (en) | 2001-10-12 | 2007-08-09 | Aquestive Therapeutics, Inc. | Thin film with non-self-aggregating uniform heterogeneity, process for their production and drug delivery systems made thereform |
JP4795639B2 (en) | 2001-10-12 | 2011-10-19 | モノソル・アールエックス・エルエルシー | Glucan-based film delivery system |
US20030224090A1 (en) | 2002-02-11 | 2003-12-04 | Edizone, Lc | Snacks of orally soluble edible films |
WO2005074894A1 (en) * | 2004-01-30 | 2005-08-18 | Corium International | Rapidly dissolving film for delivery of an active agent |
-
1999
- 1999-09-14 US US09/395,104 patent/US6596298B2/en not_active Expired - Lifetime
- 1999-09-23 DK DK99969668T patent/DK1115372T3/en active
- 1999-09-23 CN CN99811215A patent/CN1321080A/en active Pending
- 1999-09-23 DE DE69931380T patent/DE69931380T2/en not_active Expired - Lifetime
- 1999-09-23 SI SI9930907T patent/SI1115372T1/en unknown
- 1999-09-23 JP JP2000571886A patent/JP2002525306A/en not_active Ceased
- 1999-09-23 ID IDW20010533A patent/ID27740A/en unknown
- 1999-09-23 EP EP06007765A patent/EP1676557A3/en not_active Withdrawn
- 1999-09-23 WO PCT/US1999/022115 patent/WO2000018365A2/en active Application Filing
- 1999-09-23 AU AU60593/99A patent/AU771862B2/en not_active Ceased
- 1999-09-23 EE EEP200100186A patent/EE200100186A/en unknown
- 1999-09-23 CN CN201010166332A patent/CN101810547A/en active Pending
- 1999-09-23 PT PT99969668T patent/PT1115372E/en unknown
- 1999-09-23 TW TW088116383A patent/TWI238067B/en active
- 1999-09-23 BR BRPI9917781-1A patent/BR9917781B1/en not_active IP Right Cessation
- 1999-09-23 GT GT199900164A patent/GT199900164A/en unknown
- 1999-09-23 BR BRPI9914064-0A patent/BR9914064B1/en not_active IP Right Cessation
- 1999-09-23 GT GT199900164AK patent/GT199900164AA/en unknown
- 1999-09-23 TW TW094112737A patent/TWI286943B/en not_active IP Right Cessation
- 1999-09-23 KR KR1020017003793A patent/KR20010075347A/en not_active Application Discontinuation
- 1999-09-23 EP EP99969668A patent/EP1115372B1/en not_active Expired - Lifetime
- 1999-09-23 AT AT99969668T patent/ATE326203T1/en active
- 1999-09-23 CA CA002339353A patent/CA2339353C/en not_active Expired - Lifetime
- 1999-09-23 ES ES99969668T patent/ES2260961T3/en not_active Expired - Lifetime
- 1999-09-23 IL IL14191999A patent/IL141919A0/en not_active IP Right Cessation
- 1999-09-24 UY UY25728A patent/UY25728A1/en unknown
- 1999-09-24 CO CO99060702A patent/CO4940396A1/en unknown
- 1999-09-24 AR ARP990104816A patent/AR020513A1/en active IP Right Grant
- 1999-09-24 CO CO99060702D patent/CO4930288A1/en unknown
- 1999-09-24 PE PE1999000971A patent/PE20000972A1/en not_active Application Discontinuation
- 1999-09-24 PA PA19998482401A patent/PA8482401A1/en unknown
-
2001
- 2001-02-28 ZA ZA200101706A patent/ZA200101706B/en unknown
- 2001-03-22 NO NO20011476A patent/NO20011476D0/en unknown
- 2001-04-18 US US09/836,474 patent/US7025983B2/en not_active Expired - Lifetime
-
2002
- 2002-02-21 US US10/081,018 patent/US20030008008A1/en active Pending
- 2002-03-19 HK HK02102078.9A patent/HK1040619A1/en unknown
-
2003
- 2003-04-17 US US10/418,368 patent/US6923981B2/en not_active Expired - Lifetime
- 2003-10-14 US US10/684,778 patent/US7407669B2/en not_active Expired - Fee Related
-
2004
- 2004-09-15 US US10/941,193 patent/US20050031675A1/en not_active Abandoned
-
2005
- 2005-10-13 US US11/249,874 patent/US7491406B2/en not_active Expired - Fee Related
-
2006
- 2006-07-25 CY CY20061101029T patent/CY1105213T1/en unknown
-
2008
- 2008-01-14 AR ARP080100167A patent/AR064901A2/en unknown
- 2008-06-03 US US12/132,276 patent/US7867509B2/en not_active Expired - Fee Related
- 2008-07-03 IL IL192633A patent/IL192633A0/en unknown
Patent Citations (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3803300A (en) * | 1970-03-18 | 1974-04-09 | H Pospischil | Ointment foil and method of preparing the same |
US4562020A (en) * | 1982-12-11 | 1985-12-31 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Process for producing self-supporting glucan film |
US4623394A (en) * | 1984-04-14 | 1986-11-18 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Gradually disintegrable molded article |
EP0161681A2 (en) * | 1984-05-17 | 1985-11-21 | Mitsubishi Acetate Co., Ltd. | Gel plate and process for preparing same |
JPS6272609A (en) * | 1985-09-26 | 1987-04-03 | Sunstar Inc | Bathing agent |
JPS62135417A (en) * | 1985-12-09 | 1987-06-18 | Sato Seiyaku Kk | Filmy pharmaceutical |
US5023082A (en) * | 1986-05-18 | 1991-06-11 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Sustained-release pharmaceutical compositions |
EP0256611A1 (en) * | 1986-08-08 | 1988-02-24 | Squibb Japan Inc. | Oral drug delivery systems |
JPS63310818A (en) * | 1987-06-12 | 1988-12-19 | Sato Seiyaku Kk | Sheet preparation to be applied to oral mucosa |
US5629003A (en) * | 1990-06-07 | 1997-05-13 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Rapidly disintegrating sheet-like presentations of multiple dosage units |
EP0471558A2 (en) * | 1990-08-14 | 1992-02-19 | Unilever Plc | Moisture barrier and its preparation |
JPH04321619A (en) * | 1991-02-27 | 1992-11-11 | Nisshin Oil Mills Ltd:The | Composition for bath |
WO1993003649A1 (en) * | 1991-08-23 | 1993-03-04 | Gillette Canada Inc. | Sustained-release martrices for dental application |
US5700478A (en) * | 1993-08-19 | 1997-12-23 | Cygnus, Inc. | Water-soluble pressure-sensitive mucoadhesive and devices provided therewith for emplacement in a mucosa-lined body cavity |
US5741510A (en) * | 1994-03-30 | 1998-04-21 | Lectec Corporation | Adhesive patch for applying analgesic medication to the skin |
EP0750905A2 (en) * | 1995-06-27 | 1997-01-02 | Kao Corporation | Patch comprising water soluble adhesive sheet |
EP0781546A1 (en) * | 1995-12-26 | 1997-07-02 | Sanwa Kagaku Kenkyusho Co., Ltd. | A multi-layered film preparation |
WO1997031621A1 (en) * | 1996-02-29 | 1997-09-04 | Warner-Lambert Company | Delivery system for localized administration of medicaments to the upper respiratory tract |
EP0803243A2 (en) * | 1996-04-24 | 1997-10-29 | Pfizer Inc. | Cyclodextrins and phenolic compounds in dental products |
WO1998020862A1 (en) * | 1996-11-11 | 1998-05-22 | Lts Lohmann Therapie-Systeme Gmbh | Immediate wettability water soluble film or water soluble layer for oral application |
Non-Patent Citations (6)
Title |
---|
DATABASE WPI Week 199015 Derwent Publications Ltd., London, GB; AN 1990-110447 XP002129504 "ORAL CAVITY MUCOSA-ATTACHING TYPE HALITOSIS PREVENTING AGENT" & JP 02 059513 A (KYUKYU YAKUHIN KOGYO KK) , 28 February 1990 (1990-02-28) & PATENT ABSTRACTS OF JAPAN vol. 014, no. 236 & JP 02 059513 A , 28 February 1990 (1990-02-28) * |
PATENT ABSTRACTS OF JAPAN vol. 011, no. 268 (C-444), 29 August 1987 (1987-08-29) & JP 62 072609 A (SUNSTAR INC), 3 April 1987 (1987-04-03) * |
PATENT ABSTRACTS OF JAPAN vol. 011, no. 365 (C-460), 27 November 1987 (1987-11-27) & JP 62 135417 A (SATO SEIYAKU KK), 18 June 1987 (1987-06-18) & DATABASE WPI Week 198730 Derwent Publications Ltd., London, GB; AN 1987-209276 TATARA MITSUTOSHI ET AL.: "Filmy pharmaceutical" & JP 62 135417 A (SATO SEIYAKU KK), 18 June 1987 (1987-06-18) * |
PATENT ABSTRACTS OF JAPAN vol. 013, no. 156 (C-585), 14 April 1989 (1989-04-14) & JP 63 310818 A (SATO SEIYAKU KK), 19 December 1988 (1988-12-19) & DATABASE WPI Week 198905 Derwent Publications Ltd., London, GB; AN 1989-036767 TATARA MITSUTOSHI ET AL.: "Sheet preparation to be applied to oral mucosa" & JP 63 310818 A (SATO SEIYAKU KK), 19 December 1988 (1988-12-19) * |
PATENT ABSTRACTS OF JAPAN vol. 017, no. 158 (C-1041), 29 March 1993 (1993-03-29) & JP 04 321619 A (NISSHIN OIL MILLS LTD:THE), 11 November 1992 (1992-11-11) * |
SHIH FREDERICK F: "Edible films from rice protein concentrate and pullulan." CEREAL CHEMISTRY, vol. 73, no. 3, 1996, pages 406-409, XP000929432 * |
Cited By (174)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1674078A3 (en) * | 2000-03-23 | 2007-07-25 | Warner-Lambert Company LLC | Fast dissolving orally consumable filsm containing an ion exchange resin as a taste masking agent |
US7648712B2 (en) | 2000-03-23 | 2010-01-19 | Mcneil-Ppc, Inc. | Fast dissolving orally consumable films containing a taste masking agent |
WO2002002085A2 (en) * | 2000-07-04 | 2002-01-10 | Lts Lohmann Therapie-Systeme Ag | Rapidly-decomposing administrable form for releasing active ingredients in the oral cavity or in bodily cavities |
WO2002002085A3 (en) * | 2000-07-04 | 2002-06-20 | Lohmann Therapie Syst Lts | Rapidly-decomposing administrable form for releasing active ingredients in the oral cavity or in bodily cavities |
US7988997B2 (en) | 2000-07-04 | 2011-08-02 | Lts Lohmann Therapie-Systeme Ag | Rapidly-decomposing administrable form for releasing active ingredients in the oral cavity or in bodily cavities |
EP1588701A3 (en) * | 2000-07-04 | 2008-07-23 | LTS Lohmann Therapie-Systeme AG | Rapidly-decomposing dosage form for releasing nicotine in the oral cavity or in bodily cavities |
US8313769B2 (en) | 2000-07-04 | 2012-11-20 | Lts Lohmann Therapie-Systeme Ag | Rapidly disintegrating dosage form for releasing active ingredients in the oral cavity or in body cavities |
EP1588701A2 (en) | 2000-07-04 | 2005-10-26 | LTS Lohmann Therapie-Systeme AG | Rapidly-decomposing dosage form for releasing nicotine in the oral cavity or in bodily cavities |
USRE45666E1 (en) | 2000-07-07 | 2015-09-08 | A.V. Topchiev Institute Of Petrochemical Synthesis | Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties |
WO2002045714A1 (en) * | 2000-12-04 | 2002-06-13 | The Procter & Gamble Company | Drug formulation having improved oral tolerability |
WO2002049578A1 (en) * | 2000-12-20 | 2002-06-27 | Henkel Kommanditgesellschaft Auf Aktien | Remineralising dental adhesive film |
EP1370206A4 (en) * | 2001-01-09 | 2006-04-05 | Lavipharm Lab Inc | Devices for local and systemic delivery of active substances and methods of manufacturing thereof |
EP1370206A1 (en) * | 2001-01-09 | 2003-12-17 | Lavipharm Laboratories, Inc. | Devices for local and systemic delivery of active substances and methods of manufacturing thereof |
JP2004532814A (en) * | 2001-01-09 | 2004-10-28 | ラヴィファーム・ラボラトリーズ・インク | Apparatus for local and systemic delivery of actives and method of making same |
US7208519B2 (en) | 2001-01-23 | 2007-04-24 | Van Beek Natural Science, Llc | Pesticidal compounds and compositions |
US6844369B2 (en) | 2001-01-23 | 2005-01-18 | Van Beek Global, Llc | Pesticidal compounds and compositions |
WO2002058469A1 (en) * | 2001-01-23 | 2002-08-01 | Van Beek, Ron | Pesticidal compounds and compositions |
US8906406B2 (en) | 2001-02-19 | 2014-12-09 | Lts Lohmann Therapie-Systeme Ag | Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine |
DE10107659B4 (en) * | 2001-02-19 | 2008-03-13 | Lts Lohmann Therapie-Systeme Ag | Mucoadhesive disintegratable drug preparation for drug administration in veterinary and human medicine |
WO2002066016A2 (en) * | 2001-02-19 | 2002-08-29 | Lts Lohmann Therapie-Systeme Ag | Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine |
AU2002250904B2 (en) * | 2001-02-19 | 2006-05-04 | Lts Lohmann Therapie-Systeme Ag | Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine |
WO2002066016A3 (en) * | 2001-02-19 | 2003-10-02 | Lohmann Therapie Syst Lts | Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine |
JP2009185078A (en) * | 2001-02-19 | 2009-08-20 | Lts Lohmann Therapie-Systeme Ag | Mucoadhesive disintegratable pharmaceutical preparation for dosing active-agent in veterinary and human medicine |
EP2324821A1 (en) * | 2001-02-28 | 2011-05-25 | Axiomedic Ltd. | Oral care compositions |
EP1236466A1 (en) * | 2001-02-28 | 2002-09-04 | Efrat Biopolymers Ltd. | Absorbable solid compositions for topical treatment of oral mucosal disorders |
US8980334B2 (en) | 2001-02-28 | 2015-03-17 | Axiomedic Ltd. | Double-layered absorbable solid compositions for the topical treatment of oral mucosal disorders |
US7943169B2 (en) | 2001-02-28 | 2011-05-17 | Axiomedic Ltd | Absorbable solid compositions for topical treatment of oral mucosal disorders |
US8481059B2 (en) | 2001-05-01 | 2013-07-09 | A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Sciences | Hydrogel compositions |
US10179096B2 (en) | 2001-05-01 | 2019-01-15 | Corium International, Inc. | Hydrogel compositions for tooth whitening |
US9084723B2 (en) | 2001-05-01 | 2015-07-21 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Hydrogel compositions with an erodible backing member |
US10869947B2 (en) | 2001-05-01 | 2020-12-22 | Corium, Inc. | Hydrogel compositions |
US10835454B2 (en) | 2001-05-01 | 2020-11-17 | Corium, Inc. | Hydrogel compositions with an erodible backing member |
US8821901B2 (en) | 2001-05-01 | 2014-09-02 | A.V. Topchiev Institute Of Petrochemical Synthesis Russian Academy Of Sciences | Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components |
US9089481B2 (en) | 2001-05-01 | 2015-07-28 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Hydrogel compositions demonstrating phase separation on contact with aqueous media |
US8741331B2 (en) | 2001-05-01 | 2014-06-03 | A. V. Topchiev Institute of Petrochemicals Synthesis, Russian Academy of Sciences | Hydrogel compositions with an erodible backing member |
US8840918B2 (en) | 2001-05-01 | 2014-09-23 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Hydrogel compositions for tooth whitening |
US8481071B2 (en) | 2001-05-01 | 2013-07-09 | Corium International, Inc. | Hydrogel compositions with an erodible backing member |
US9687428B2 (en) | 2001-05-01 | 2017-06-27 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Hydrogel compositions for tooth whitening |
US8541021B2 (en) | 2001-05-01 | 2013-09-24 | A.V. Topchiev Institute Of Petrochemical Synthesis | Hydrogel compositions demonstrating phase separation on contact with aqueous media |
US9532935B2 (en) | 2001-05-01 | 2017-01-03 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Hydrogel compositions for tooth whitening |
US8617647B2 (en) | 2001-05-01 | 2013-12-31 | A.V. Topchiev Institutes of Petrochemical Synthesis, Russian Academy of Sciences | Water-absorbent adhesive compositions and associated methods of manufacture and use |
US9127140B2 (en) | 2001-05-01 | 2015-09-08 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Water-absorbent adhesive compositions and associated methods of manufacture and use |
US8273405B2 (en) | 2001-05-01 | 2012-09-25 | A.V. Topcheiv Institute of Petrochemical Synthesis, Russian Academy of Sciences | Water-absorbent adhesive compositions and associated methods of manufacture and use |
US8728445B2 (en) | 2001-05-01 | 2014-05-20 | A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Sciences | Hydrogel Compositions |
US9259504B2 (en) | 2001-05-01 | 2016-02-16 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Non-electrically conductive hydrogel composition |
US6740332B2 (en) | 2001-07-30 | 2004-05-25 | Wm. Wrigley Jr. Company | Edible film formulations containing maltodextrin |
US6656493B2 (en) | 2001-07-30 | 2003-12-02 | Wm. Wrigley Jr. Company | Edible film formulations containing maltodextrin |
US6419903B1 (en) * | 2001-08-20 | 2002-07-16 | Colgate Palmolive Company | Breath freshening film |
KR100912850B1 (en) * | 2001-09-25 | 2009-08-18 | 규큐 야쿠힝 고교 가부시키가이샤 | Nicotine-containing film preparation |
EP1430896A1 (en) * | 2001-09-25 | 2004-06-23 | Kyukyu Pharmaceutical Co., Ltd. | Nicotine−containing film preparation |
EP1430896A4 (en) * | 2001-09-25 | 2007-10-31 | Kyukyu Yakuhin Kogyo Kk | Nicotine-containing film preparation |
US11077068B2 (en) | 2001-10-12 | 2021-08-03 | Aquestive Therapeutics, Inc. | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
US7897080B2 (en) | 2001-10-12 | 2011-03-01 | Monosol Rx, Llc | Polyethylene-oxide based films and drug delivery systems made therefrom |
US8900497B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for making a film having a substantially uniform distribution of components |
US8663687B2 (en) | 2001-10-12 | 2014-03-04 | Monosol Rx, Llc | Film compositions for delivery of actives |
US8900498B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for manufacturing a resulting multi-layer pharmaceutical film |
AU2002332118B2 (en) * | 2001-10-12 | 2008-06-26 | Aquestive Therapeutics, Inc. | Glucan based film delivery systems |
US11207805B2 (en) | 2001-10-12 | 2021-12-28 | Aquestive Therapeutics, Inc. | Process for manufacturing a resulting pharmaceutical film |
US9855221B2 (en) | 2001-10-12 | 2018-01-02 | Monosol Rx, Llc | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
WO2003030881A1 (en) * | 2001-10-12 | 2003-04-17 | Kosmos Pharma | Glucan based film delivery systems |
US8906277B2 (en) | 2001-10-12 | 2014-12-09 | Monosol Rx, Llc | Process for manufacturing a resulting pharmaceutical film |
US8652378B1 (en) | 2001-10-12 | 2014-02-18 | Monosol Rx Llc | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
US20150056268A1 (en) * | 2001-10-12 | 2015-02-26 | Monosol Rx, Llc | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
US9931305B2 (en) | 2001-10-12 | 2018-04-03 | Monosol Rx, Llc | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
US8685437B2 (en) | 2001-10-12 | 2014-04-01 | Monosol Rx, Llc | Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
JP4795639B2 (en) * | 2001-10-12 | 2011-10-19 | モノソル・アールエックス・エルエルシー | Glucan-based film delivery system |
JP2005528328A (en) * | 2001-10-12 | 2005-09-22 | コスモス・ファーマ | Glucan-based film delivery system |
US10285910B2 (en) | 2001-10-12 | 2019-05-14 | Aquestive Therapeutics, Inc. | Sublingual and buccal film compositions |
US8765167B2 (en) | 2001-10-12 | 2014-07-01 | Monosol Rx, Llc | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
US9108340B2 (en) | 2001-10-12 | 2015-08-18 | Monosol Rx, Llc | Process for manufacturing a resulting multi-layer pharmaceutical film |
US10888499B2 (en) | 2001-10-12 | 2021-01-12 | Aquestive Therapeutics, Inc. | Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
US7910031B2 (en) | 2001-10-12 | 2011-03-22 | Monosol Rx, Llc | Process for forming an ingestible thin film with non-self-aggregating uniform heterogeneity |
AU2002347165B2 (en) * | 2001-12-11 | 2008-05-29 | Ceapro Inc. | Cereal beta glucan compositions, methods of preparation and uses thereof |
EP1790687A3 (en) * | 2001-12-11 | 2007-07-25 | Ceapro Inc. | Cereal beta glucan compositions, methods of preparation and uses thereof |
WO2003054077A1 (en) * | 2001-12-11 | 2003-07-03 | Ceapro Inc. | Cereal beta glucan compositions, methods of preparation and uses thereof |
US8632798B2 (en) | 2001-12-11 | 2014-01-21 | Ceapro Inc. | Cereal β glucan compositions, methods of preparation and uses thereof |
US10111810B2 (en) | 2002-04-11 | 2018-10-30 | Aquestive Therapeutics, Inc. | Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
EP1542903B1 (en) | 2002-07-22 | 2015-05-20 | MonoSolRX, LLC | Packaging and dispensing of rapid dissolve dosage form |
CN100421639C (en) * | 2002-07-23 | 2008-10-01 | 高露洁-棕榄公司 | Enzyme enhanced breath freshening film |
AU2003252046B2 (en) * | 2002-07-23 | 2009-08-13 | Colgate-Palmolive Company | Enzyme enhanced breath freshening film |
WO2004009050A1 (en) * | 2002-07-23 | 2004-01-29 | Colgate-Palmolive Company | Enzyme enhanced breath freshening film |
WO2004012720A1 (en) * | 2002-07-26 | 2004-02-12 | Pfizer Limited | Process for making orally consumable dosage forms |
WO2004024111A1 (en) * | 2002-09-16 | 2004-03-25 | Cp Kelco, U.S., Inc. | Pectin films |
US6916463B2 (en) | 2002-09-24 | 2005-07-12 | The Procter & Gamble Company | Oral products having an aesthetic layer |
US10398644B2 (en) | 2002-11-14 | 2019-09-03 | Cure Pharmaceutical Corporation | Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films |
EP1560571A2 (en) * | 2002-11-14 | 2005-08-10 | Innozen, Inc. | Edible film for relief of cough or symptoms associated with pharyngitis |
EP1560571A4 (en) * | 2002-11-14 | 2007-11-28 | Innozen Inc | Edible film for relief of cough or symptoms associated with pharyngitis |
WO2004052335A1 (en) * | 2002-12-06 | 2004-06-24 | Monosolrx Llc | Thin film delivery systems for volatile decongestants |
WO2004058231A3 (en) * | 2002-12-26 | 2004-11-04 | Univ Manitoba | Dissolving film comprising a therapeutically active agent within the film or in a pouch formed by the film |
WO2004058231A2 (en) * | 2002-12-26 | 2004-07-15 | University Of Manitoba | Dissolving film comprising a therapeutically active agent within the film or in a pouch formed by the film |
US6669929B1 (en) * | 2002-12-30 | 2003-12-30 | Colgate Palmolive Company | Dentifrice containing functional film flakes |
US9827172B2 (en) | 2002-12-30 | 2017-11-28 | Colgate-Palmolive Company | Dentifrice containing functional film flakes |
US9498410B2 (en) | 2002-12-30 | 2016-11-22 | Colgate-Palmolive Company | Oral and personal care compositions and methods |
US9918909B2 (en) | 2002-12-30 | 2018-03-20 | Colgate-Palmolive Company | Oral and personal care compositions and methods |
JP2011068689A (en) * | 2003-01-30 | 2011-04-07 | Monosol Rx Llc | Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made from the same |
CN100356908C (en) * | 2003-01-30 | 2007-12-26 | 莫诺索尔克斯有限公司 | Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
JP2015098494A (en) * | 2003-01-30 | 2015-05-28 | モノソル・アールエックス・エルエルシー | Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
WO2004066986A1 (en) * | 2003-01-30 | 2004-08-12 | Monosolrx Llc | Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
EP2428206A1 (en) * | 2003-01-30 | 2012-03-14 | MonoSol RX LLC | Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
JP2013028635A (en) * | 2003-01-30 | 2013-02-07 | Monosol Rx Llc | Thin film with non-self-aggregating uniform heterogeneity and drug delivery system made from the same |
US7041311B2 (en) | 2003-02-28 | 2006-05-09 | International Flavors & Fragrances Inc. | Preparation for saliva flow |
WO2004087089A3 (en) * | 2003-03-26 | 2005-01-20 | Procter & Gamble | Rapidly dissolving edible film compositions with improved film strength and stability |
WO2004087089A2 (en) * | 2003-03-26 | 2004-10-14 | The Procter & Gamble Company | Rapidly dissolving edible film compositions with improved film strength and stability |
US9155698B2 (en) | 2003-03-28 | 2015-10-13 | Cure Pharmaceutical Corporation | Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films |
US8840919B2 (en) | 2003-03-28 | 2014-09-23 | Cure Pharmaceutical Corporation | Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films |
WO2004089336A3 (en) * | 2003-04-02 | 2005-03-17 | Procter & Gamble | Drug delivery systems comprising an encapsulated active ingredient |
WO2004089336A2 (en) * | 2003-04-02 | 2004-10-21 | The Procter & Gamble Company | Drug delivery systems comprising an encapsulated active ingredient |
WO2004091528A3 (en) * | 2003-04-14 | 2005-01-27 | Fmc Corp | Delivery systems of homogeneous thermoreversible alginate films |
WO2004091528A2 (en) * | 2003-04-14 | 2004-10-28 | Fmc Corporation | Delivery systems of homogeneous thermoreversible alginate films |
WO2004105758A1 (en) * | 2003-05-30 | 2004-12-09 | The Boots Company Plc | Use of tripolidine in providing refreshedness on waking |
EP1648362A2 (en) * | 2003-07-01 | 2006-04-26 | Todd Maibach | Film comprising therapeutic agents |
EP1648362A4 (en) * | 2003-07-01 | 2012-01-11 | Todd Maibach | Film comprising therapeutic agents |
EP1656018A1 (en) * | 2003-08-22 | 2006-05-17 | Innozen, Inc. | Edible films for administration of medicaments to animals |
EP1656018A4 (en) * | 2003-08-22 | 2008-07-23 | Innozen Inc | Edible films for administration of medicaments to animals |
US7666396B2 (en) | 2003-09-11 | 2010-02-23 | Kimberly-Clark Worldwide, Inc. | Single-use moisturizing product |
US7285520B2 (en) | 2003-12-01 | 2007-10-23 | Kimberly-Clark Worldwide, Inc. | Water disintegratable cleansing wipes |
US8106152B2 (en) | 2003-12-19 | 2012-01-31 | Dairy Australia Limited | Antimicrobial composition |
EP1713450A4 (en) * | 2004-01-30 | 2012-06-27 | Corium Int Inc | Rapidly dissolving film for delivery of an active agent |
US9144552B2 (en) | 2004-01-30 | 2015-09-29 | A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Sciences | Rapidly dissolving film for delivery of an active agent |
US8658201B2 (en) | 2004-01-30 | 2014-02-25 | Corium International, Inc. | Rapidly dissolving film for delivery of an active agent |
US10154679B2 (en) | 2004-02-03 | 2018-12-18 | Cargill, Incorporated | Protein concentrate and an aqueous stream containing water-soluble carbohydrates |
US9226515B2 (en) | 2004-02-03 | 2016-01-05 | Cargill, Incorporated | Protein concentrate and an aqueous stream containing water-soluble carbohydrates |
WO2005082332A2 (en) * | 2004-02-20 | 2005-09-09 | National Starch And Chemical Investment Holding Corporation | Dissolvable film comprising an active ingredient and method of manufacture |
WO2005082332A3 (en) * | 2004-02-20 | 2005-11-24 | Nat Starch Chem Invest | Dissolvable film comprising an active ingredient and method of manufacture |
WO2005082048A3 (en) * | 2004-02-20 | 2005-11-17 | Nat Starch Chem Invest | Dissolvable film and method of manufacture |
WO2005082048A2 (en) * | 2004-02-20 | 2005-09-09 | National Starch And Chemical Investment Holding Corporation | Dissolvable film and method of manufacture |
US9499419B2 (en) | 2004-09-27 | 2016-11-22 | Special Waters Patents B.V. | Methods and compositions for treatment of skin |
US7888404B2 (en) | 2005-02-02 | 2011-02-15 | Novapharm Research (Australia) Pty Ltd | Biostatic polymer |
WO2006081617A1 (en) * | 2005-02-02 | 2006-08-10 | Novapharm Research (Australia) Pty Ltd | Biostatic polymer |
US9179669B2 (en) | 2005-02-02 | 2015-11-10 | Novapharm Research (Australia) Pty Ltd | Biostatic polymer formed articles |
US8062686B2 (en) | 2005-04-12 | 2011-11-22 | InovoBiologics, Inc. | Dietary supplement, and methods of use |
US8597709B2 (en) | 2005-04-12 | 2013-12-03 | Inovobiologic Inc. | Dietary supplement and methods of use |
US10010102B2 (en) | 2005-04-12 | 2018-07-03 | Inovobiologic Inc. | Dietary supplement and methods of use |
EP3871693A1 (en) | 2005-09-27 | 2021-09-01 | Special Water Patents B.V. | Compositions for oral care |
WO2008028278A1 (en) * | 2006-09-05 | 2008-03-13 | University Of Manitoba | Antimicrobial coatings |
US7972618B2 (en) * | 2006-09-20 | 2011-07-05 | Monosol Rx, Llc | Edible water-soluble film containing a foam reducing flavoring agent |
WO2008108940A1 (en) * | 2007-03-05 | 2008-09-12 | Mcneil-Ppc, Inc. | Fast-dissolving/disintegrating film preparation having high proportion of active |
EP2444076A1 (en) * | 2007-03-05 | 2012-04-25 | McNeil-PPC, Inc. | Fast-dissolving/disintegrating film preparation having high proportion of active agent |
AU2008223583B2 (en) * | 2007-03-05 | 2013-08-15 | Mcneil-Ppc, Inc. | Fast-dissolving/disintegrating film preparation having high proportion of active |
US8105625B2 (en) | 2007-04-05 | 2012-01-31 | University Of Kansas | Rapidly dissolving pharmaceutical compositions comprising pullulan |
US8900629B2 (en) | 2007-04-05 | 2014-12-02 | University Of Kansas | Rapidly dissolving pharmaceutical compositions comprising pullulan |
WO2008137164A1 (en) * | 2007-05-07 | 2008-11-13 | Hwa-Song Liu | Edible thin film strips and process for making |
CN101073407B (en) * | 2007-06-15 | 2011-04-20 | 广东富味制果厂有限公司 | Edible refreshing pearl and its production |
US8968709B2 (en) | 2007-07-25 | 2015-03-03 | 3M Innovative Properties Company | Therapeutic dental composition and related methods |
WO2009017708A2 (en) * | 2007-07-31 | 2009-02-05 | Bill Mcanalley | Compositions, uses, and method of making wound care products from naturally occurring food ingredients |
WO2009017708A3 (en) * | 2007-07-31 | 2009-03-19 | Bill Mcanalley | Compositions, uses, and method of making wound care products from naturally occurring food ingredients |
EP2187970A4 (en) * | 2007-08-10 | 2015-06-03 | Genic Co Ltd | Dissolvable nano web porous film and method of preparing the same |
US9610253B2 (en) | 2009-01-14 | 2017-04-04 | Corium International, Inc. | Transdermal administration of tamsulosin |
US8784879B2 (en) | 2009-01-14 | 2014-07-22 | Corium International, Inc. | Transdermal administration of tamsulosin |
US10238612B2 (en) | 2009-01-14 | 2019-03-26 | Corium International, Inc. | Transdermal administration of tamsulosin |
EP2422764A4 (en) * | 2009-04-23 | 2013-01-09 | Lotte Co Ltd | Composition for use in the oral cavity |
US10821074B2 (en) | 2009-08-07 | 2020-11-03 | Aquestive Therapeutics, Inc. | Sublingual and buccal film compositions |
US10034833B2 (en) | 2009-08-07 | 2018-07-31 | Aquestive Therapeutics, Inc. | Sublingual and buccal film compositions |
US11135216B2 (en) | 2009-08-07 | 2021-10-05 | Indivior Uk Limited | Sublingual and buccal film compositions |
US9687454B2 (en) | 2009-08-07 | 2017-06-27 | Indivior Uk Limited | Sublingual and buccal film compositions |
US8475832B2 (en) | 2009-08-07 | 2013-07-02 | Rb Pharmaceuticals Limited | Sublingual and buccal film compositions |
US9504857B2 (en) | 2010-01-29 | 2016-11-29 | Colgate-Palmolive Company | Oral care formulations for malodor control |
US8974826B2 (en) | 2010-06-10 | 2015-03-10 | Monosol Rx, Llc | Nanoparticle film delivery systems |
DE102010048408A1 (en) | 2010-10-15 | 2012-04-19 | Lts Lohmann Therapie-Systeme Ag | Laminate with improved water retention behavior |
WO2012048816A1 (en) | 2010-10-15 | 2012-04-19 | Lts Lohmann Therapie-Systeme Ag | Laminate having improved water retention characteristics |
US10940626B2 (en) | 2010-10-22 | 2021-03-09 | Aquestive Therapeutics, Inc. | Manufacturing of small film strips |
US10272607B2 (en) | 2010-10-22 | 2019-04-30 | Aquestive Therapeutics, Inc. | Manufacturing of small film strips |
DE102013000700A1 (en) * | 2012-10-04 | 2014-04-10 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Composition useful e.g. for treating inflammatory diseases of oral and pharyngeal cavity, comprises virustatic and/or antiviral polysaccharide, surface disinfectant, optionally acidic glycosaminoglycan and optionally local anesthetic |
US11191737B2 (en) | 2016-05-05 | 2021-12-07 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine compositions |
US11273131B2 (en) | 2016-05-05 | 2022-03-15 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
DE102017112527A1 (en) | 2017-06-07 | 2018-12-13 | Lts Lohmann Therapie-Systeme Ag | Fast disintegrating foam wafers with a high basis weight |
DE102017112527B4 (en) | 2017-06-07 | 2019-01-03 | Lts Lohmann Therapie-Systeme Ag | Fast disintegrating foam wafers with a high basis weight |
WO2018224591A1 (en) | 2017-06-07 | 2018-12-13 | Lts Lohmann Therapie-Systeme Ag | Quickly disintegrating foam wafer with high mass per unit area |
DE102017127434A1 (en) | 2017-11-21 | 2019-05-23 | Lts Lohmann Therapie-Systeme Ag | Pocket-shaped oral-release films with high drug loading |
WO2019101800A2 (en) | 2017-11-21 | 2019-05-31 | Lts Lohmann Therapie-Systeme Ag | Pouch-type orally dissolving films with high active ingredient concentration |
DE102019100483A1 (en) | 2019-01-10 | 2020-07-16 | Lts Lohmann Therapie-Systeme Ag | Oral thin film |
WO2020144345A1 (en) | 2019-01-10 | 2020-07-16 | Lts Lohmann Therapie-Systeme Ag | Oral thin film |
WO2021030247A1 (en) * | 2019-08-14 | 2021-02-18 | Intercontinental Great Brands Llc | Confectionery chip product; and methods of making the same |
WO2022106923A1 (en) | 2020-11-18 | 2022-05-27 | BioPharma Synergies, S. L. | Orodispersible powder composition comprising an antihistamine compound |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6596298B2 (en) | Fast dissolving orally comsumable films | |
CA2520986C (en) | Physiological compatible film | |
US20030211136A1 (en) | Fast dissolving orally consumable films containing a sweetener | |
US20040115137A1 (en) | Water-soluble film for oral administration | |
AU2008207405A1 (en) | Cereal beta glucan compositions, methods of preparation and uses thereof | |
CA2523372A1 (en) | Fast dissolving orally consumable films containing a modified starch for improved heat and moisture resistance | |
CA2572461C (en) | Physiological compatible film | |
MXPA01001539A (en) | Fast dissolving orally consumable films | |
BR9917782B1 (en) | method for the preparation of a physiologically compatible film. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 1200100145 Country of ref document: VN Ref document number: 99811215.1 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AU BA BB BG BR CA CN CR CU CZ DM EE GD GE HR HU ID IL IN IS JP KP KR LC LK LR LT LV MG MK MN MX NO NZ PL RO SG SI SK SL TR TT TZ UA UZ VN YU ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AU BA BB BG BR CA CN CR CU CZ DM EE GD GE HR HU ID IL IN IS JP KP KR LC LK LR LT LV MG MK MN MX NO NZ PL RO SG SI SK SL TR TT TZ UA UZ VN YU ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
ENP | Entry into the national phase |
Ref document number: 2339353 Country of ref document: CA Ref document number: 2339353 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2001/001539 Country of ref document: MX Ref document number: IN/PCT/2001/00146/MU Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001/01706 Country of ref document: ZA Ref document number: 200101706 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 60593/99 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 141919 Country of ref document: IL Ref document number: 1999969668 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2000 571886 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020017003793 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 1999969668 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020017003793 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 60593/99 Country of ref document: AU |
|
WWR | Wipo information: refused in national office |
Ref document number: 1020017003793 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 1999969668 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 192633 Country of ref document: IL |